include,reason,title,doi,pubmed_id
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes.",Comparison of Bedtime Insulin Regimens in Patients with Type Diabetes Mellitus,https://doi.org/10.7326/0003-4819-130-5-199903020-00002,10068412
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting investigating the effect of a sulfonylurea (glibenclamide) on a clinically relevant outcome (ischaemic tolerance during exercise tests).",Effects of KATPchannel blockade by glibenclamide on the warmup phenomenon,https://doi.org/10.1053/euhj.1998.1311,10082152
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, uses sulfonylureas as the intervention, and reports clinically relevant outcomes.",Shortterm intensive insulin therapy as a method of overcoming secondary failure of sulfonylureas in patients with type diabetes noninsulindependent,nan,10085698
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it compares the efficacy and safety of repaglinide and glyburide in adults with type 2 diabetes.",A year multicenter randomized doubleblind comparison of repaglinide and glyburide for the treatment of type diabetes Dutch and German Repaglinide Study Group,https://doi.org/10.2337/diacare.22.3.463,10097930
False," The study does not meet the inclusion criteria for intervention as it only includes sulfonylureas and short-acting secretagogues, whereas the inclusion criteria specify sulfonylureas as one of the interventions.",A short term costeffectiveness model for oral antidiabetic medicines in Europe,10.2165/00019053-199813030-00006,10178657
True," The study meets all the inclusion criteria as it is a systematic analysis of clinical and economic effects of bodyweight stabilisation with acarbose in patients with type 2 diabetes, and it is a fair quality study.",Evaluation of the Potential Clinical and Economic Effects of Bodyweight Stabilisation with Acarbose in Patients with Type Diabetes Mellitus,https://doi.org/10.2165/00019053-199813040-00007,10178668
True," The study is a systematic review of clinical trials with original data, and it meets the inclusion criteria of focusing on adults with type 2 diabetes treated with troglitazone.",Troglitazone,https://doi.org/10.2165/00003495-199957030-00014,10193691
True," The study meets all the inclusion criteria as it is a double-blind, placebo-controlled study of adults with diabetes, evaluating the effects of sulfonylureas, and reports clinically relevant outcomes.",Sulfonylureas and ischaemic preconditioning a doubleblind placebocontrolled evaluation of glimepiride and glibenclamide,https://doi.org/10.1053/euhj.1998.1242,10213347
True, The study meets the inclusion criteria as it is a study on the effect of a sulfonylurea (gliclazide) on plasma insulin and proinsulin in South Asian subjects with Type 2 diabetes.,The effect of gliclazide on plasma insulin intact and split proinsulin in South Asian subjects with Type diabetes mellitus,https://doi.org/10.1046/j.1464-5491.1999.00025.x,10229308
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial comparing the effects of repaglinide and glyburide in well-controlled type 2 diabetic patients, and it reports original data.",A doubleblind randomized comparison of mealrelated glycemic control by repaglinide and glyburide in wellcontrolled type diabetic patients,https://doi.org/10.2337/diacare.22.5.789,10332683
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, comparing the effect of repaglinide in combination with metformin with metformin monotherapy in patients with type 2 diabetes.",Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type diabetes,https://doi.org/10.2337/diacare.22.1.119,10333912
False, The study does not meet the inclusion criteria as it does not involve interventions by sulfonylureas or short-acting secretagogues.,The relationship between glucose and incident cardiovascular events A metaregression analysis of published data from studies of individuals followed for years,https://doi.org/10.2337/diacare.22.2.233,10333939
False," The study only compares the effects of two specific oral antidiabetic agents (sulphonylurea and biguanide derivative) on plasma amylin levels, not a broad range of sulfonylureas.",Effect of Oral Antidiabetic Agents on Plasma Amylin Level in Patients with Noninsulindependent Diabetes mellitus Type,https://doi.org/10.1055/s-0031-1300423,10337452
True, The study meets all the inclusion criteria as it is a good quality systematic review of a randomized controlled trial in an outpatient setting with clinically relevant outcomes.,Glycemic Control With Diet Sulfonylurea Metformin or Insulin in Patients With Type Diabetes MellitusSUBTITLEProgressive Requirement for Multiple Therapies UKPDS SUBTITLE,https://doi.org/10.1001/jama.281.21.2005,10359389
True," The study meets all the inclusion criteria as it is a study on adults with type 2 diabetes treated with oral hypoglycemic agents, and it reports original data.",Morning Blood Glucose Determination in the Monitoring of Metabolic Control in Type Elderly Diabetic Cases Treated by Oral Hypoglycemic Agents,https://doi.org/10.3143/geriatrics.36.122,10363530
True," The study meets all the inclusion criteria as it is a clinical trial with original data, investigates the effect of a specific oral hypoglycemic drug (troglitazone), and reports clinically relevant outcomes.",Effect of troglitazone on body fat distribution in type diabetic patients,https://doi.org/10.2337/diacare.22.6.908,10372240
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, comparing the efficacy and safety of repaglinide and glibenclamide in the treatment of type 2 diabetes patients previously treated with sulphonylureas.",A comparison of repaglinide and glibenclamide in the treatment of type diabetic patients previously treated with sulphonylureas,https://doi.org/10.1007/s002280050613,10379630
True," The study meets all the inclusion criteria as it is a systematic review of rosiglitazone's effects on type 2 diabetes, includes adults of different races, ages, and genders, and reports on clinically relevant outcomes.",Rosiglitazone,https://doi.org/10.2165/00003495-199957060-00007,10400405
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the effects of a specific oral hypoglycemic drug (troglitazone) on blood pressure in an outpatient setting.",Vasodilatory Effects of Troglitazone Improve Blood Pressure at Rest and During Mental Stress in Type Diabetes Mellitus,https://doi.org/10.1161/01.hyp.34.1.83,10406828
True," The study meets all inclusion criteria as it is a high-quality study discussing a potential treatment for type 2 diabetes, and it is written in English.",Highdose biotin an inducer of glucokinase expression may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes,https://doi.org/10.1054/mehy.1997.0682,10416947
True," The study meets the inclusion criteria as it is a good quality study examining the recovery of ventricular function in children with idiopathic dilated cardiomyopathy, which is a clinically relevant outcome.",Late recovery of ventricular function in children with idiopathic dilated cardiomyopathy,https://doi.org/10.1016/s0002-8703(99)70121-3,10426848
False, The article does not meet the inclusion criteria as it does not involve the specified oral hypoglycemic drugs (sulfonylureas or short-acting secretagogues) and does not focus on adults with type 2 diabetes.,Clinical Pharmacokinetics and Pharmacodynamics of Bromfenac,https://doi.org/10.2165/00003088-199936060-00002,10427465
True," The study meets all the inclusion criteria as it is a systematic review of studies on the treatment of type 2 diabetes with sulfonylureas and short-acting secretagogues, and it includes clinically relevant outcomes.",Type Diabetes An Overview,https://doi.org/10.1093/clinchem/45.8.1339,10430816
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes treated with a sulfonylurea (glyburide).",A comparison of preconstituted fixed combinations of lowdose glyburide plus metformin versus highdose glyburide alone in the treatment of type diabetic patients,https://doi.org/10.1007/s005920050146,10436254
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",Effects of combination of insulin and acarbose compared with insulin and gliclazide in type diabetic patients,https://doi.org/10.1007/s005920050151,10436259
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, uses sulfonylureas as the intervention, and reports clinically relevant outcomes.",Higher incidence of severe hypoglycaemia leading to hospital admission in Type diabetic patients treated with longacting versus shortacting sulphonylureas,https://doi.org/10.1046/j.1464-5491.1999.00110.x,10445835
True," The study meets all the inclusion criteria as it is a systematic review of oral agents for type 2 diabetes, includes adults of different races, ages, and gender, and focuses on clinically relevant outcomes.",Pharmacologic therapy for type diabetes mellitus,10.7326/0003-4819-131-4-199908170-00008,10454950
False," The article does not meet the inclusion criteria as it is a case report and does not contain original data from a systematic review or a double-blind, randomized controlled trial.",Hypoglycemia associated with high doses of sertraline and sulphonylurea compound in a noninsulindependent diabetes mellitus patient,nan,10465860
False," The study does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, and it does not involve an intervention with sulfonylureas or short-acting secretagogues.",Glucose tolerance and mortality comparison of WHO and American Diabetes Association diagnostic criteria The DECODE study group European Diabetes Epidemiology Group Diabetes Epidemiology Collaborative analysis Of Diagnostic criteria in Europe,nan,10466661
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, and investigates glucose effectiveness and insulin sensitivity in elderly type 2 diabetic patients.",Reduced glucose effectiveness as a feature of glucose intolerance Evidence in elderly Type diabetic subjects,https://doi.org/10.1007/bf03399659,10476312
True, The study meets the inclusion criteria as it is a good quality study examining the association between glucose intolerance and risk of coronary heart disease and total mortality in a cohort of Japanese-American men.,Glucose intolerance and year risk of coronary heart disease and total mortality the Honolulu Heart Program,https://doi.org/10.2337/diacare.22.8.1262,10480768
False," The study does not meet the inclusion criteria as it does not involve adults with type 2 diabetes, and the intervention is not by sulfonylureas or short-acting secretagogues.",Carnitine transport and its inhibition by sulfonylureas in human kidney proximal tubular epithelial cells,https://doi.org/10.1016/s0006-2952(99)00219-1,10487540
False," The study does not meet the inclusion criteria as it is not an intervention study, but rather a longitudinal observational study examining the natural history of type 2 diabetes.",The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type diabetes mellitus,https://doi.org/10.1172/jci7231,10491414
True," The study provides original data on the pharmacokinetics of troglitazone, a thiazolidinedione oral antidiabetic agent, in adults with type 2 diabetes.",Clinical Pharmacokinetics of Troglitazone,https://doi.org/10.2165/00003088-199937020-00001,10496299
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses repaglinide as an intervention, and reports clinically relevant outcomes.",Absorption metabolism and excretion of a single oral dose of Crepaglinide during repaglinide multiple dosing,https://doi.org/10.1007/s002280050667,10501822
False," The study does not meet the inclusion criteria as it is focused on the metabolism of rosiglitazone, not the effects of sulfonylureas or short-acting secretagogues on type 2 diabetes.",Characterization of the cytochrome P enzymes involved in the in vitro metabolism of rosiglitazone,https://doi.org/10.1046/j.1365-2125.1999.00030.x,10510156
True," The study appears to be a systematic review or double-blind, randomized controlled trial, focusing on adults with type 2 diabetes treated with sulfonylureas or short-acting secretagogues, and includes clinically relevant outcomes.",Recent advances in pharmacological treatment of type diabetes mellitus,https://doi.org/10.1007/bf02944293,10520444
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glibenclamide) as the intervention, and reports clinically relevant outcomes related to glucose homeostasis.",Interaction of sulfonylureas and exercise on glucose homeostasis in type diabetic patients,https://doi.org/10.2337/diacare.22.10.1647,10526729
True," The study appears to be a systematic review of oral antidiabetic agents, focusing on their effects beyond glucose level lowering, which meets the inclusion criteria.",A Review of Metabolic and Cardiovascular Effects of Oral Antidiabetic Agents Beyond GlucoseLevel Lowering,https://doi.org/10.1177/204748739900600512,10534139
True," The study meets the inclusion criteria as it is a double-blind, randomized controlled trial (crossover design) in an outpatient setting, examining the effects of combination therapy with insulin and sulphonylureas in adults with type 2 diabetes.",The lipoprotein profile differs during insulin treatment alone and combination therapy with insulin and sulphonylureas in patients with Type diabetes mellitus,https://doi.org/10.1046/j.1464-5491.1999.00170.x,10547208
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it investigates the effect of sulphonylurea in combination therapy in adults with type 2 diabetes.",The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal,https://doi.org/10.1046/j.1464-5491.1999.00171.x,10547209
True," The study meets all the inclusion criteria as it is a systematic review of a model comparing the costs of first-line monotherapy strategies for type 2 diabetes, includes adults of different races, ages, and gender, and focuses on clinically relevant outcomes.",A shortterm costoftreatment model for type diabetes comparison of glipizide gastrointestinal therapeutic system metformin and acarbose,nan,10558125
False," The study does not meet the inclusion criteria as it is a case report of a single patient, not a systematic review or double-blind, randomized controlled trial.",The effect of octreotide on glucose and insulin levels in a patient with type diabetes on glibenclamide,nan,10566126
False," The study does not meet the inclusion criteria as it is not a systematic review or a double-blind, randomized controlled trial, but rather a single study assessing the efficacy of a specific combination therapy.",Insulin lispro in the treatment of patients with type diabetes mellitus after oral agent failure,https://doi.org/10.1016/s0149-2918(99)80049-6,10566566
False," The article does not contain original data, as it is a discussion of current management practices and guidelines rather than a presentation of new research findings.",Strategies for Better Diabetes Control in the US,https://doi.org/10.2165/00003495-199958001-00014,10576528
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glyburide) as the intervention, and is a double-blind, randomized controlled trial in an inpatient setting, examining a clinically relevant outcome (low blood glucose).",Lowdose ethanol predisposes elderly fasted patients with type diabetes to sulfonylureainduced low blood glucose,https://doi.org/10.2337/diacare.22.12.2037,10587839
True," The study meets all the inclusion criteria as it is a systematic review of a double-blind, randomized controlled trial of repaglinide in adults with type 2 diabetes, comparing it to sulfonylureas, and reports on clinically relevant outcomes.",Repaglinide a new compound for the treatment of patients with type diabetes,https://doi.org/10.1016/s0300-2977(99)00068-6,10593133
True," The study meets all the inclusion criteria as it is a systematic investigation of drug interactions between thioctic acid and two oral hypoglycemic drugs, glibenclamide and acarbose, in healthy volunteers.",Lack of interaction between thioctic acid glibenclamide and acarbose,https://doi.org/10.1046/j.1365-2125.1999.00097.x,10594485
True," The study meets all the inclusion criteria as it discusses oral pharmacologic management of type 2 diabetes in adults, includes good and fair quality studies, and focuses on clinically relevant outcomes.",Oral pharmacologic management of type diabetes,nan,10605995
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of a short-acting secretagogue (repaglinide) in adults with type 2 diabetes, and reports clinically relevant outcomes.",Repaglinide in Type Diabetes A Week FixedDose Efficacy and Safety Study,https://doi.org/10.1177/00912700022008694,10631622
True," The study meets all the inclusion criteria as it is a systematic review of the use of sulphonylureas in elderly patients with type 2 diabetes, includes clinically relevant outcomes, and is written in English.",The Use of Sulphonylureas in the Elderly,https://doi.org/10.2165/00002512-199915060-00007,10641958
True," The article meets all the inclusion criteria as it is a systematic review of oral hypoglycemic agents, includes adults with type 2 diabetes, and focuses on clinically relevant outcomes.",New directions in type diabetes mellitus an update of current oral antidiabetic therapy,nan,10643211
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the pharmacokinetics of a short-acting secretagogue (repaglinide).",SingleDose Pharmacokinetics of Repaglinide in Subjects with Chronic Liver Disease,https://doi.org/10.1177/00912700022008793,10664920
True," The study meets all the inclusion criteria as it is a systematic review of a randomized clinical trial in an outpatient setting, assessing clinically relevant outcomes in adults with type 2 diabetes treated with sulfonylureas.",Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type diabetes,https://doi.org/10.1016/s0149-2918(00)87983-7,10688395
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes treated with sulphonylureas.",Addition of lowdose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type diabetic patients,https://doi.org/10.1046/j.1464-5491.2000.00224.x,10691158
True, The study meets all the inclusion criteria as it is a good quality study that compares the pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes.,Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type diabetes,https://doi.org/10.1046/j.1365-2125.2000.00162.x,10718777
True," The study meets the inclusion criteria as it discusses the use of repaglinide in combination therapy for type 2 diabetes, involves a relevant intervention (repaglinide or sulfonylureas), and focuses on clinically relevant outcomes.",Repaglinide in combination therapy in type diabetes,nan,10746009
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it includes clinically relevant outcomes such as glycemic control and quality of life.",Comparative Efficacy and Potency of LongTerm Therapy with Glipizide or Glyburide in Patients with Type Diabetes Mellitus,https://doi.org/10.1016/s0002-9629(15)40712-8,10746824
True," The study meets all the inclusion criteria as it is a double-blind, placebo-controlled trial examining the effects of a specific oral hypoglycemic agent (nateglinide) on insulin secretion in patients with Type 2 diabetes.",Effects of the new oral hypoglycaemic agent nateglinide on insulin secretion in Type diabetes mellitus,https://doi.org/10.1046/j.1464-5491.2000.00256.x,10784228
False," The study does not involve adults with type 2 diabetes, but rather healthy volunteers.",Lack of Interaction between Tolcapone and Tolbutamide in Healthy Volunteers,https://doi.org/10.1177/00912700022009161,10806608
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in adults with type 2 diabetes, investigating the efficacy and safety of cerivastatin, a statin, in an outpatient setting.",Efficacy and Safety of Cerivastatin for Type Diabetes and Hypercholesterolemia,https://doi.org/10.1177/204748739900600607,10817086
True," The study meets all the inclusion criteria as it is a good quality double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes treated with sulfonylureas.",Cost effectiveness of an intensive blood glucose control policy in patients with type diabetes economic analysis alongside randomised controlled trial UKPDS,https://doi.org/10.1136/bmj.320.7246.1373,10818026
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but the study is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it examines clinically relevant outcomes.",Erythromycin improves glycaemic control in patients with Type II diabetes mellitus,https://doi.org/10.1007/s001250051323,10819233
True," The abstract contains original data and discusses the use of various antidiabetic agents in the management of type 2 diabetes, which aligns with the inclusion criteria.",Recent Developments and Emerging Therapies for Type Diabetes Mellitus,https://doi.org/10.2165/00126839-199902020-00001,10820647
False, The paper does not contain original data as it appears to be a product description or advertisement for a medication.,Pharmaclinics Medication of the month Glimepiride Amarylle,nan,10823010
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, examining the effect of repaglinide on insulin secretion in healthy subjects.",Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency,https://doi.org/10.2337/diacare.23.5.675,10834429
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with adults with type 2 diabetes, examining the effect of a short-acting secretagogue (repaglinide) on insulin secretion.",Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type diabetes,https://doi.org/10.2337/diacare.23.4.518,10857945
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a relevant intervention (oral hypoglycemic agents), and reports clinically relevant outcomes.",Effects of oral hypoglycemic agents and diet on protein metabolism in type diabetes,https://doi.org/10.2337/diacare.23.1.1,10857959
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes treated with a short-acting secretagogue (nateglinide).",Rapid and shortacting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia,https://doi.org/10.2337/diacare.23.2.202,10868832
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it involves the intervention of a short-acting secretagogue (nateglinide).",Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin,https://doi.org/10.2337/diacare.23.3.349,10868864
True," The study meets all the inclusion criteria as it is a double-blind, crossover study of nateglinide in patients with type 2 diabetes, and it reports original data on clinically relevant outcomes.",Mealtime glucose regulation by nateglinide in type diabetes mellitus,https://doi.org/10.1007/s002280050730,10877006
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glibenclamide) as the intervention, and reports clinically relevant outcomes.",Effects of glibenclamide a katpchannel blocker on warmup phenomenon in type diabetic patients with chronic stable angina pectoris,https://doi.org/10.1002/clc.4960230713,10894443
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it includes clinically relevant outcomes such as glycemic control.",Repaglinidetroglitazone combination therapy improved glycemic control in type diabetes,https://doi.org/10.2337/diacare.23.7.979,10895850
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it examines the response of pancreatic beta-cells to improved insulin sensitivity in adults with impaired glucose tolerance and a history of gestational diabetes.",Response of pancreatic betacells to improved insulin sensitivity in women at high risk for type diabetes,https://doi.org/10.2337/diabetes.49.5.782,10905487
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, includes clinically relevant outcomes, and is of good quality.",Troglitazone or metformin in combination with sulfonylureas for patients with type diabetes,nan,10907625
True," The article meets all the inclusion criteria as it is a systematic review of studies on the management of type 2 diabetes, specifically focusing on sulfonylureas and short-acting secretagogues, and includes clinically relevant outcomes.",A Rational Approach to Drug Therapy of Type Diabetes Mellitus,https://doi.org/10.2165/00003495-200060010-00006,10929931
False," The study does not meet the inclusion criteria as it is focused on bioequivalence of two glipizide tablet preparations in healthy volunteers, not adults with type 2 diabetes.",A bioequivalence study of two brands of glipizide tablets,nan,10934787
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it includes clinically relevant outcomes such as quality of life and all-cause mortality.",Less nocturnal hypoglycemia and better postdinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type diabetes HOE Study Group,https://doi.org/10.2337/diacare.23.8.1130,10937510
False, The study does not contain original data as it is a non-systematic review of existing findings.,The KQ variant of the human PC gene is not associated with insulin resistance or type diabetes among Danish Caucasians,https://doi.org/10.2337/diabetes.49.9.1608,10969849
False," The study does not meet the inclusion criteria as it is a cohort study, not a systematic review or double-blind, randomized controlled trial.",Oral hypoglycaemic agents in diabetic pregnancies,https://doi.org/10.1046/j.1464-5491.2000.00314.x,10972579
False," The article does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, but rather a general overview of pharmacological treatments for postprandial hyperglycemia.",Pharmacological treatment of postprandial hyperglycemia,nan,10975046
True," The study meets all the inclusion criteria as it is a systematic review of a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes.",Therapy focused on lowering postprandial glucose not fasting glucose may be superior for lowering HbAc IOEZ Study Group,https://doi.org/10.2337/diacare.23.9.1236,10977012
True," The study meets all the inclusion criteria as it is a systematic review of the effects of pioglitazone in patients with type 2 diabetes, including adults of different races, ages, and genders, and it reports on clinically relevant outcomes.",Pioglitazone,https://doi.org/10.2165/00003495-200060020-00009,10983737
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes treated with a sulfonylurea (glibenclamide), and examines clinically relevant outcomes such as the occurrence of mild hypoglycemia.",Does holiday hypoglycaemia exist,nan,11019600
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it includes clinically relevant outcomes such as glycemic control and hypoglycemic events.",Longterm dietary treatment with increased amounts of fiberrich lowglycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type diabetic patients,https://doi.org/10.2337/diacare.23.10.1461,11023137
True," The study meets all the inclusion criteria as it is a systematic review of a double-blind, randomized controlled trial in adults with type 2 diabetes, comparing the effects of nateglinide with other treatments.",Nateglinide,https://doi.org/10.2165/00003495-200060030-00007,11030470
True," The study meets all the inclusion criteria as it is a systematic review of the pharmacological properties of nateglinide, includes adults with type 2 diabetes, and focuses on clinically relevant outcomes.",Pharmacological properties of Nateglinide rapidonsetshortduration insulinotropic agent in the treatment of Type diabetes,https://doi.org/10.1254/fpj.116.171,11031747
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves the use of a sulfonylurea (glyburide), and it includes clinically relevant outcomes such as maternal and neonatal complications.",A Comparison of Glyburide and Insulin in Women with Gestational Diabetes Mellitus,https://doi.org/10.1056/nejm200010193431601,11036118
False," The abstract does not mention anything about oral hypoglycemic drugs for gestational diabetes, but rather discusses the diagnosis and treatment of gestational diabetes in general.",Oral Hypoglycemic Drugs for Gestational Diabetes,https://doi.org/10.1056/nejm200010193431608,11036125
True," The study meets all the inclusion criteria as it is a systematic review of repaglinide, a short-acting secretagogue, in patients with type 2 diabetes, and it reports on clinically relevant outcomes.",Pharmacology and clinical experience with repaglinide,https://doi.org/10.1517/13543784.9.4.885,11060717
False, The abstract does not mention the specific inclusion criteria of the intervention being either sulfonylureas or short-acting secretagogues.,Insulin sensitiser drugs,https://doi.org/10.1517/13543784.9.6.1347,11060747
True," The study meets the inclusion criteria as it is a prospective study of adults with type 2 diabetes, comparing the effects of different oral hypoglycemic agents on dyslipidaemia.",The effect of oral hypoglycaemic agents on dyslipidaemia in Nigerian patients with newly diagnosed noninsulin dependent diabetes mellitusa prospective study,nan,11070748
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type diabetes,https://doi.org/10.2337/diacare.23.11.1660,11092289
True," The study meets the inclusion criteria as it is a fair quality study on adults with type 2 diabetes, assessing the effects of a natural intervention (Withania somnifera root powder) on blood glucose and cholesterol levels.",Hypoglycemic diuretic and hypocholesterolemic effect of winter cherry Withania somnifera Dunal root,nan,11116534
True," The study meets all the inclusion criteria as it is a systematic review of the management of type 2 diabetes and cardiovascular risk, includes adults of different races, ages, and gender, and focuses on clinically relevant outcomes.",Management of Type Diabetes Mellitus and Cardiovascular Risk,https://doi.org/10.2165/00003495-200060050-00001,11129129
False," The article does not meet the inclusion criteria for intervention as it mentions various classes of agents (sulfonylureas, short-acting secretagogues, insulin, and others) but does not specifically focus on sulfonylureas or short-acting secretagogues.",RECENT ADVANCES IN THE PHARMACOLOGIC MANAGEMENT OF DIABETES MELLITUS,https://doi.org/10.1016/s0733-8627(05)70156-5,11130936
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with diabetes, uses a sulfonylurea (glimepiride), and is a double-blind, randomized controlled trial in an outpatient setting.",Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride,https://doi.org/10.1046/j.1365-2125.2000.00295.x,11136298
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes of a specific race, uses a relevant intervention (sulfonylurea), and reports clinically relevant outcomes.",Nearnormoglycaemic remission in AfricanAmericans with Type diabetes mellitus is associated with recovery of beta cell function,https://doi.org/10.1046/j.1464-5491.2001.00395.x,11168335
True," The study meets the inclusion criteria as it is a systematic review is not mentioned but it is a randomized crossover study, and it involves adults with type 2 diabetes and assesses the pharmacokinetics of a specific oral hypoglycemic drug combination.",Pharmacokinetics and Bioavailability of a MetforminGlyburide Tablet Administered Alone and with Food,https://doi.org/10.1177/009127000004001222,11185672
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it involves the use of a short-acting secretagogue (repaglinide).",Flexible MealRelated Dosing With Repaglinide Facilitates Glycemic Control in TherapyNaive Type Diabetes,https://doi.org/10.2337/diacare.24.1.11,11194214
False," The study does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, and it does not involve an intervention with oral hypoglycemic drugs.",Diastolic Dysfunction in Normotensive Men with WellControlled Type Diabetes,https://doi.org/10.2337/diacare.24.1.5,11194240
True," The study meets all inclusion criteria as it is a good quality study, involves adults with healthy volunteers, uses a relevant intervention (nateglinide and repaglinide), and is a systematic study in an outpatient setting.",Mealtime Glucose Regulation With Nateglinide in Healthy Volunteers,https://doi.org/10.2337/diacare.24.1.73,11194245
True," The study meets all the inclusion criteria as it is a systematic review of studies on intensive glycaemic control in type 2 diabetes, includes adults of different races, ages, and gender, and focuses on clinically relevant outcomes.",Beneficial and Detrimental Effects of Intensive Glycaemic Control with Emphasis on Type Diabetes Mellitus,https://doi.org/10.2165/00002512-200017060-00004,11200307
True," The study meets all the inclusion criteria as it is a systematic review of a specific intervention (nateglinide) in adults with type 2 diabetes, and it reports original data.",Impairment of Early Insulin Response after Glucose Load Rather than Insulin Resistance is Responsible for Postprandial Hyperglycemia Seen in Obese Type Diabetes Assessment Using Nateglinide a New Insulin Secretagogue,https://doi.org/10.1507/endocrj.47.639,11200947
True," The study meets all the inclusion criteria as it is a systematic review of the effects and pharmacokinetics of oral glibenclamide and glipizide in Caucasian and Chinese patients with type 2 diabetes, and it is a double-blind, randomized controlled trial.",Effects and pharmacokinetics of oral glibenclamide and glipizide in Caucasian and Chinese patients with type diabetes,https://doi.org/10.1007/s002280000214,11214781
True," The study meets all the inclusion criteria as it is a fair quality study, includes adults with type 2 diabetes, and examines the effect of short-acting oral antidiabetic drugs on leptin levels in female patients.",Leptin concentrations are related to glycaemic control but do not change with shortterm oral antidiabetic therapy in female patients with type diabetes mellitus,https://doi.org/10.1046/j.1463-1326.2000.00073.x,11225747
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, comparing the effects of metformin and sulfonylurea on proinsulin levels and cardiovascular risk factors in patients with type 2 diabetes.",Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type diabetes,https://doi.org/10.1046/j.1463-1326.1999.00034.x,11228758
True," The study meets all the inclusion criteria as it is a systematic review of the management of type 2 diabetes in the elderly, includes clinically relevant outcomes, and is written in English.",Management of Type Diabetes Mellitus in the Elderly,https://doi.org/10.2165/00002512-200118010-00003,11232737
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it compares the effects of two oral hypoglycemic drugs, glybenclamide and metformin.",The ShortTerm Effect of a Switch from Glybenclamide to Metformin on Blood Pressure and Microalbuminuria in Patients with Type Diabetes Mellitus,https://doi.org/10.1016/s0188-4409(00)00241-1,11257323
True," The study meets all the inclusion criteria as it is a fair quality study involving adults with type 2 diabetes, comparing the effects of sulfonylurea and biguanide in patients with different initial serum insulin levels.",Serum insulin assay an important therapeutic tool in management of freshly diagnosed type diabetes mellitus,nan,11273476
False," The study does not meet the inclusion criteria as it is focused on children with type 1 diabetes, not adults with type 2 diabetes.",Blood Pressure Does Not Rise Before the Onset of Microalbuminuria in Children Followed From Diagnosis of Type Diabetes,https://doi.org/10.2337/diacare.24.3.555,11289484
False," The study does not meet the inclusion criteria as it focuses on hormone replacement therapy in postmenopausal women with type 2 diabetes, which does not match the specified intervention of sulfonylureas or short-acting secretagogues.",Lipid and Lipoprotein Responses to Oral Combined Hormone Replacement Therapy in Normolipemic Obese Women with Controlled Type Diabetes Mellitus,https://doi.org/10.1177/009127009803801204,11301562
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting investigating the effects of a sulfonylurea (glibenclamide) on patients with cirrhosis and type 2 diabetes.",Hemodynamic Metabolic and Hormonal Responses to Oral Glibenclamide in Patients with Cirrhosis Receiving Glucose,https://doi.org/10.1080/003655201750074654,11305519
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glibenclamide) as the intervention, and reports clinically relevant outcomes.",Sulfonylurea Treatment of Type Diabetic Patients Does Not Reduce the Vasodilator Response to Ischemia,https://doi.org/10.2337/diacare.24.4.738,11315840
True," The study meets all the inclusion criteria as it involves adults with type 2 diabetes, uses insulin and sulfonylureas as interventions, and includes clinically relevant outcomes such as glycemia and body weight.",Combination Therapies With Insulin in Type Diabetes,https://doi.org/10.2337/diacare.24.4.758,11315844
True," The article meets all the inclusion criteria as it is a clinical review of glimepiride, includes adults with type 2 diabetes, and discusses clinically relevant outcomes.",Clinical review of glimepiride,https://doi.org/10.1517/14656566.2.4.699,11336617
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (gliclazide modified release) as the intervention, and reports clinically relevant outcomes.",hour glycemic profile in type diabetic patients treated with gliclazide modified release once daily,nan,11353879
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, comparing the effects of nateglinide and glyburide on insulin secretion in patients with type 2 diabetes, and reports clinically relevant outcomes.",Importance of Early Insulin Secretion,https://doi.org/10.2337/diacare.24.6.983,11375357
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial (crossover design) in an outpatient setting, and it reports original data on adults with type 2 diabetes.",The effects of inorganic chromium and brewers yeast supplementation on glucose tolerance serum lipids and drug dosage in individuals with type diabetes,nan,11376359
True," The article meets all the inclusion criteria as it is a systematic review of studies on type 2 diabetes treatment, includes adults of different races, ages, and gender, and focuses on clinically relevant outcomes.",Matching treatment to pathophysiology in type diabetes,https://doi.org/10.1016/s0149-2918(01)80017-5,11394726
False," The article does not contain original data, as it is a narrative review of the glitazones.",Lessons from the glitazones a story of drug development,https://doi.org/10.1016/s0140-6736(00)04960-6,11410214
False," The abstract does not contain original data, as it appears to be a review of existing literature rather than presenting new research findings.",Tissue Triglyceride Levels In Type Diabetes And The Role Of Thiazolidinediones In Reversing The Effects Of Tissue Hypertriglyceridemia Review Of The Evidence In Animals And Humans,https://doi.org/10.4158/ep.7.2.135,11421558
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes treated with diet.",Randomized Dose Ranging Study of the Reduction of Fasting and Postprandial Glucose in Type Diabetes by Nateglinide A,https://doi.org/10.2337/diacare.24.7.1221,11423506
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes treated with sulfonylureas.",Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type diabetes mellitus a randomized placebocontrolled study,https://doi.org/10.1016/s0002-9343(01)00713-6,11448655
True," The study meets all the inclusion criteria as it is a systematic review of the pharmacology, pharmacokinetics, clinical efficacy, adverse effects, interactions, and dosage of nateglinide, which is an oral hypoglycemic agent used to treat type 2 diabetes mellitus.",Nateglinide,https://doi.org/10.1093/ajhp/58.13.1200,11449877
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (gliclazide) as the intervention, and is a double-blind, randomized controlled trial.",Mechanisms of acute and chronic hypoglycemic action of gliclazide,https://doi.org/10.1007/s005920070006,11450504
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, and examines the effect of a specific sulfonylurea (glyburide) in combination with metformin on clinically relevant outcomes.",Oral antidiabetic treatment in patients with coronary disease Timerelated increased mortality on combined glyburidemetformin therapy over a year followup,https://doi.org/10.1002/clc.4960240210,11460818
True," The study mentions the potential of lipoic acid as an adjunctive antidiabetic agent with insulin-sensitizing activity, which aligns with the topic of the review.",Lipoic Acid A Multifunctional Antioxidant That Improves Insulin Sensitivity in Patients with Type Diabetes,https://doi.org/10.1089/15209150050194279,11467343
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial comparing the effectiveness of repaglinide and glipizide in patients with type 2 diabetes, and reports clinically relevant outcomes such as HbA1c and fasting blood glucose levels.",Comparison between repaglinide and glipizide in Type diabetes mellitus a year multicentre study,https://doi.org/10.1046/j.1464-5491.2001.00490.x,11472451
False," The study does not meet the inclusion criteria as it is a retrospective analysis of administrative pharmacy claims data and does not involve a systematic review or double-blind, randomized controlled trial.",Utilization of Oral Hypoglycemic Agents in a DrugInsured US Population,https://doi.org/10.2337/diacare.24.8.1411,11473078
True, The study meets all the inclusion criteria as it is a systematic review of recent scientific documentation from long-term studies on treatment effects of sulfonylureas and short-acting secretagogues in type 2 diabetes.,Hypoglycemic treatment of type diabetes,nan,11475233
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, and it reports on the effects of a short-acting secretagogue (repaglinide) in adults with type 2 diabetes.",Pharmacokinetics Pharmacodynamics and DoseResponse Relationship of Repaglinide in Type Diabetes,https://doi.org/10.1089/152091599317143,11475269
False, The article does not contain original data as it appears to be a product information sheet or a medication guide rather than a research paper.,Pharmaclinics Medication of the month Repaglinide NovoNorm,nan,11496727
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the effects of sulfonylureas and insulin in an outpatient setting.",Differences in pharmacotherapy and in glucose control of type diabetes patients in two neighbouring towns a longitudinal populationbased study,https://doi.org/10.1046/j.1463-1326.2001.00110.x,11520304
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, compares repaglinide to another sulfonylurea (glibenclamide), and reports on clinically relevant outcomes.",Repaglinide potentially a therapeutic improvement for diabetes mellitus type,nan,11525087
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",Effects of improved glycaemic control on endothelial function in patients with type diabetes,https://doi.org/10.1046/j.1445-5994.2001.00072.x,11529585
True," The study appears to be a systematic review of therapeutic targets in type 2 diabetes, which meets the inclusion criteria of being a good or fair quality study, focusing on adults with type 2 diabetes, and discussing clinically relevant outcomes.",Objetivos y estrategia teraputica en la diabetes mellitus tipo,https://doi.org/10.4321/s0212-71992001000700010,11534426
True," The study meets all the inclusion criteria as it is a systematic review of studies on endothelial dysfunction in type 2 diabetes, includes adults of different races, ages, and genders, and focuses on the effects of sulfonylureas and short-acting secretagogues on endothelial function.",Endothelial dysfunction and type diabetes Part altered endothelial function and the effects of treatments in type diabetes mellitus,nan,11547217
False," The study does not meet the inclusion criteria as it is focused on type 1 diabetes with secondary failure of sulphonylureas, whereas the review is focused on type 2 diabetes.",Intramuscular injection of insulin lispro or soluble human insulin pharmacokinetics and glucodynamics in Type diabetes,https://doi.org/10.1046/j.1464-5491.2001.00522.x,11553186
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, and evaluates the effect of sulfonylureas, a relevant intervention, in an outpatient setting.",Betacell function evaluated by HOMA as a predictor of secondary sulphonylurea failure in Type diabetes,https://doi.org/10.1046/j.1464-5491.2001.00534.x,11553190
True," The study meets all the inclusion criteria as it is a review of rosiglitazone in type 2 diabetes, includes adults of different races, ages, and gender, and focuses on clinically relevant outcomes.",A Review of Rosiglitazone in Type Diabetes Mellitus,https://doi.org/10.1592/phco.21.13.1082.34615,11560198
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial in an outpatient setting, and it investigates the effect of a specific oral hypoglycemic drug, nateglinide, on clinically relevant outcomes.",The Effect of Food on the Oral Bioavailability and the Pharmacodynamic Actions of the Insulinotropic Agent Nateglinide in Healthy Subjects,https://doi.org/10.1177/00912709922007606,11563410
False," The abstract does not contain original data, as it appears to be a company profile or press release rather than a research study.",CLX Calyx Therapeutics,nan,11569941
True," The study meets the inclusion criteria as it is a fair quality study, involves adults with cystic fibrosis-related diabetes, and examines the effects of repaglinide and insulin lispro in an outpatient setting.",Insulin and Glucose Excursion Following Premeal Insulin Lispro or Repaglinide in Cystic FibrosisRelated Diabetes,https://doi.org/10.2337/diacare.24.10.1706,11574430
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes of different races, ages, and gender, and focuses on the effect of sulfonylureas and short-acting secretagogues.",Postchallenge Hyperglycemia in a National Sample of US Adults With Type Diabetes,https://doi.org/10.2337/diacare.24.10.1734,11574434
False, The article does not contain original data as it appears to be a review of existing studies and does not present new data.,Nateglinide a new rapidacting insulinotropic agent,https://doi.org/10.1517/14656566.2.6.1027,11585005
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glibenclamide) as the intervention, and reports clinically relevant outcomes (postprandial hypertriglyceridaemia).",Glibenclamide improves postprandial hypertriglyceridaemia in Type diabetic patients by reducing chylomicrons but not the very lowdensity lipoprotein subfraction levels,https://doi.org/10.1046/j.1464-5491.2001.00538.x,11678967
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, comparing the effect of glimepiride in combination with metformin with monotherapy of each drug on glycaemic control in Type 2 diabetic patients.",Improved glycaemic control by addition of glimepiride to metformin monotherapy in Type diabetic patients,https://doi.org/10.1046/j.1464-5491.2001.00582.x,11678974
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes of different races, ages, and gender.",Effects of Sibutramine in Obese Female Subjects With Type Diabetes and Poor Blood Glucose Control,https://doi.org/10.2337/diacare.24.11.1957,11679464
False," The study does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, and it does not involve an intervention with sulfonylureas or short-acting secretagogues.",Genetic variability of the SUR promoter in relation to betacell function and Type II diabetes mellitus,https://doi.org/10.1007/s001250100651,11692183
False, The paper does not contain original data as it is a review of existing literature on thiazolidinediones.,Thiazolidinedionesa new class of oral antidiabetics,nan,11715152
False," The abstract does not mention the use of sulfonylureas or short-acting secretagogues as interventions, which are specified in the inclusion criteria.",Medical care from childhood to adulthood in Type and Type diabetes,https://doi.org/10.1007/bf03343914,11716156
True, The study meets the inclusion criteria as it is a good quality study that examines the prescribing patterns of antihypertensive and antidiabetic drugs in patients with type 2 diabetes in an outpatient setting.,Prescribing Patterns and Therapeutic Implications for Diabetic Hypertension in Bahrain,https://doi.org/10.1345/aph.10399,11724081
True," The study meets all inclusion criteria as it is a systematic review of nateglinide, includes adults with type 2 diabetes, and discusses clinically relevant outcomes.",Nateglinide Therapy for Type Diabetes Mellitus,https://doi.org/10.1345/aph.1a061,11724096
True," The study meets all the inclusion criteria as it discusses the insulinotropic meglitinide analogues, specifically repaglinide, nateglinide, and mitiglinide, which are relevant to the topic, and it is a non-systematic review or discussion of the topic.",Insulinotropic meglitinide analogues,https://doi.org/10.1016/s0140-6736(01)06715-0,11728565
True," The study meets all the inclusion criteria as it is a systematic review of good quality studies involving adults with type 2 diabetes, comparing the effects of orlistat with sulfonylureas and short-acting secretagogues.",Orlistat,https://doi.org/10.2165/00003495-200161140-00011,11735640
True, The study meets all inclusion criteria as it is a systematic review of clinical trials examining the hepatotoxicity of thiazolidinediones in patients with type 2 diabetes.,Hepatotoxicity with Thiazolidinediones,https://doi.org/10.2165/00002018-200124120-00002,11735645
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glibenclamide) as the intervention, and reports clinically relevant outcomes.",Poststenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug glibenclamide in patients with coronary artery disease,https://doi.org/10.1136/heart.87.1.54,11751665
False, The article does not meet the inclusion criteria as it is a review paper and does not contain original data.,Current and future treatment strategies for type diabetes the betacell as a therapeutic target,nan,11763159
False," The abstract does not contain original data, as it appears to be a summary of a drug's development process rather than a study of its effects.",Pramlintide Amylin,nan,11763160
True," The study appears to meet all the inclusion criteria, including being a systematic review or double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes.",Oral Antihyperglycemic Therapy for Type Diabetes,https://doi.org/10.1001/jama.287.3.360,11790216
False," The article does not contain original data, as it is a general overview of pharmacologic approaches to type 2 diabetes rather than a systematic review or randomized controlled trial.",Oral Antihyperglycemic Therapy for Type Diabetes,https://doi.org/10.1001/jama.287.3.373,11790217
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glimepiride as the intervention, and reports clinically relevant outcomes.",Glimepiride in type diabetes mellitus Thai patients,nan,11800292
True, The study meets all the inclusion criteria as it is a systematic review of a randomized controlled trial in an outpatient setting with clinically relevant outcomes.,Sulfonylurea Inadequacy,https://doi.org/10.2337/diacare.25.2.330,11815505
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in adults with type 2 diabetes, investigating the effect of repaglinide, a short-acting secretagogue, on glycemic control.",Optimizing Insulin Secretagogue Therapy in Patients With Type Diabetes,https://doi.org/10.2337/diacare.25.2.342,11815507
False," The study does not meet the inclusion criteria as it is about sibutramine, a drug for obesity, and not about sulfonylureas or short-acting secretagogues for type 2 diabetes.",Sibutramine new preparation Slight weight loss but also a slight rise in blood pressure,nan,11824428
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it compares the efficacy of a sulfonylurea (glyburide) with a premixed insulin (Humalog Mix).",Comparative efficacy of preprandial or postprandial humalog mix versus glyburide in patients to years of age with type diabetes mellitus,https://doi.org/10.1016/s0149-2918(02)85006-8,11833837
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of two sulfonylureas (glibenclamide and gliclazide) in patients with type 2 diabetes, and it reports clinically relevant outcomes related to oxidative stress.",Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitusa double blind randomized study,nan,11837468
True," The study meets the inclusion criteria as it involves adults with type 2 diabetes of different races, ages, and gender, and it examines the pharmacokinetics and pharmacodynamics of a specific oral hypoglycemic agent, repaglinide.",Modeling the pharmacokinetics and pharmacodynamics of a unique oral hypoglycemic agent using neural networks,https://doi.org/10.1023/a:1013611617787,11837705
False," The article does not meet the inclusion criteria as it is a review of pharmacology and clinical aspects of oral antidiabetic drugs, but it does not focus on the specified interventions (sulfonylureas or short-acting secretagogues) and does not report original data.",New Trends in the Development of Oral Antidiabetic Drugs,https://doi.org/10.2174/0929867023371427,11860348
True," The study meets all the inclusion criteria as it is a double-blind, randomized crossover trial in adults with type 2 diabetes, comparing the effects of glibenclamide and acarbose on vasodilator responses to KATP channel opening.",Vascular KATP channel blockade by glibenclamide but not by acarbose in patients with Type II diabetes,https://doi.org/10.1042/cs1020307,11869171
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glibenclamide) as the intervention, and reports clinically relevant outcomes.",Effects of Treatment With Sulfonylurea Drugs or Insulin on IschemiaInduced Myocardial Dysfunction in Type Diabetes,https://doi.org/10.2337/diabetes.51.3.808,11872684
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial (crossover design) in adults with type 2 diabetes, comparing the effects of glibenclamide with glimepiride and metformin on vascular function.",Vascular effects of glibenclamide vs glimepiride and metformin in Type diabetic patients,https://doi.org/10.1046/j.1464-5491.2002.00663.x,11874430
False," The article does not contain original data, as it is a review of existing knowledge about amylin and its role in type 2 diabetes mellitus.",A is for amylin and amyloid in type diabetes mellitus,nan,11875249
False," The study does not meet the inclusion criteria as it does not involve adults with type 2 diabetes, but rather focuses on polycystic ovary syndrome.",Glucose tolerance insulin secretion and insulin sensitivity in polycystic ovary syndrome,nan,11884761
False, The article does not contain original data as it is a clinical review of oral medications.,Type diabetes management A comprehensive clinical review of oral medications,https://doi.org/10.1007/s12019-002-0042-8,11894443
False," The article does not meet the inclusion criteria as it is a review of alternative therapies for type 2 diabetes, not a systematic review or double-blind, randomized controlled trial of sulfonylureas or short-acting secretagogues.",Alternative therapies for type diabetes,nan,11896745
True," The study meets all the inclusion criteria as it is a good quality study on adults with type 2 diabetes, involves a specific sulfonylurea (glibenclamide), and reports clinically relevant outcomes.",Effects and serum levels of glibenclamide and its active metabolites in patients with type diabetes,https://doi.org/10.1046/j.1463-1326.2001.00152.x,11903411
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a randomized controlled trial, it involves adults with type 2 diabetes, and it examines clinically relevant outcomes.",The effects of intensive glycaemic control on body composition in patients with type diabetes,https://doi.org/10.1046/j.1463-1326.2001.00153.x,11903412
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, investigating the effect of glimepiride on subjects with impaired fasting glucose, and reports clinically relevant outcomes.",The NEPI Antidiabetes Study NANSY Shortterm doseeffect relations of glimepiride in subjects with impaired fasting glucose,https://doi.org/10.1046/j.1463-1326.2001.00166.x,11903417
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glyburide) as an intervention, and reports clinically relevant outcomes.",Effects of Dietary Treatment Alone or Diet With Voglibose or Glyburide on Abdominal Adipose Tissue and Metabolic Abnormalities in Patients With Newly Diagnosed Type Diabetes,https://doi.org/10.2337/diacare.25.4.658,11919121
True," The study meets the inclusion criteria as it is a retrospective analysis of patient compliance and persistence with antihyperglycemic therapy in adults with type 2 diabetes, and it reports on clinically relevant outcomes such as regimen modification and compliance.",Patient Compliance and Persistence with AntiHyperglycemic Therapy Evaluation of a Population of Type Diabetic Patients,https://doi.org/10.1177/147323000203000111,11921502
False," The study does not meet the inclusion criteria as it is not about type 2 diabetes, sulfonylureas, or short-acting secretagogues, and it is not a systematic review or double-blind, randomized controlled trial.",Evaluation of Innovative SkinMarking Technique Performed Before Thyroid UltrasoundGuided FineNeedle Aspiration Biopsies,https://doi.org/10.4158/ep.8.1.5,11939753
True," The study meets the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, and it investigates the effect of a novel controlled-release formulation of lipoic acid on glycemic control in patients with type 2 diabetes.",Pharmacokinetics Tolerability and FructosamineLowering Effect of a Novel ControlledRelease Formulation of Lipoic Acid,https://doi.org/10.4158/ep.8.1.29,11951812
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",A rapid increase in cell function by multiple insulin injections in type diabetic patients is not further enhanced by prolonging treatment,https://doi.org/10.1046/j.1365-2796.2002.00956.x,11952881
False," The article does not contain original data, as it is an overview of oral agents for type 2 diabetes treatment.",Current oral agents for type diabetes,https://doi.org/10.3810/pgm.2002.05.1194,12040862
False," The article does not contain original data, as it appears to be a review of existing literature rather than a systematic review or randomized controlled trial.",Thiazolidinediones and type diabetes new drugs for an old disease,https://doi.org/10.5694/j.1326-5377.2002.tb04461.x,12041635
False," The abstract does not mention the use of sulfonylureas or short-acting secretagogues as the intervention, which is a specified inclusion criterion.",Multiple Drug Targets in the Management of Type Diabetes,https://doi.org/10.2174/1389450023347803,12041735
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glipizide), and reports on clinically relevant outcomes.",Pharmacokinetics and Pharmacodynamics of ExtendedRelease Glipizide GITS Compared with ImmediateRelease Glipizide in Patients with Type II Diabetes Mellitus,https://doi.org/10.1177/00970002042006007,12043953
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of a short-acting secretagogue (nateglinide) in adults with type 2 diabetes, and reports clinically relevant outcomes.",Nateglinide improves glycaemic control when added to metformin monotherapy results of a randomized trial with type diabetes patients,https://doi.org/10.1046/j.1463-1326.2002.00196.x,12047396
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it includes clinically relevant outcomes such as progression or occurrence of microvascular disease.",Simultaneous glyburidemetformin therapy is superior to component monotherapy as an initial pharmacological treatment for type diabetes,https://doi.org/10.1046/j.1463-1326.2002.00211.x,12047399
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",EFFICACY AND SAFETY OF PIOGLITAZONE IN TYPE DIABETES A RANDOMISED PLACEBOCONTROLLED STUDY IN PATIENTS RECEIVING STABLE INSULIN THERAPY,nan,12074206
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes treated with a sulfonylurea (gliclazide).",Gliclazide Modified Release,https://doi.org/10.2165/00003495-200262090-00010,12076188
False," The article does not meet the inclusion criteria as it is a descriptive study of repaglinide's pharmacokinetics and pharmacodynamics, not a comparison of repaglinide with other oral hypoglycemic drugs.",Clinical Pharmacokinetics and Pharmacodynamics of Repaglinide,https://doi.org/10.2165/00003088-200241070-00002,12083976
False, The article does not contain original data as it is a review of existing literature.,Orlistat Use in Type Diabetes,https://doi.org/10.1345/aph.1a422,12086556
False," The article does not contain original data, as it is a commentary outlining basic concepts and controversial issues in the field of desensitization of insulin secretion.",Desensitization of insulin secretion,https://doi.org/10.1016/s0006-2952(02)00996-6,12093468
False," The article does not contain original data, as it is described as a discussion of the rationale for the use of oral hypoglycemic agents based on research from basic sciences and clinical studies.",Oral hypoglycemic agents and the pregnant diabetic From bench to bedside,https://doi.org/10.1053/sper.2002.33960,12099312
True," The study meets the inclusion criteria as it is a good quality study that examines the changes in oral hypoglycaemic therapy in adults with type 2 diabetes, specifically focusing on the use of sulfonylureas and short-acting secretagogues.",Changes in treatment after the start of oral hypoglycaemic therapy in Type diabetes a populationbased study,https://doi.org/10.1046/j.1464-5491.2002.00743.x,12099966
False," The study does not meet the inclusion criteria as it is focused on bioequivalence evaluation of two brands of gliclazide tablets in healthy volunteers, not adults with type 2 diabetes.",Bioequivalence evaluation of two brands of gliclazide mg tablets Glyzide Diamicron in healthy human volunteers,https://doi.org/10.1002/bdd.310,12116051
False," The article does not contain original data, as it is a general overview of oral hypoglycaemic agents and does not present any systematic review or original research findings.",Oral hypoglycaemics When not to use what,nan,12143325
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it involves the use of a sulfonylurea (glyburide) in combination with metformin.",Improved glycaemic control with metforminglibenclamide combined tablet therapy Glucovance in Type diabetic patients inadequately controlled on metformin,https://doi.org/10.1046/j.1464-5491.2002.00774.x,12147149
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes of different races, ages, and gender.",Rosiglitazone,https://doi.org/10.2165/00003495-200262120-00007,12149047
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",Combination Therapy With Nateglinide and a Thiazolidinedione Improves Glycemic Control in Type Diabetes,https://doi.org/10.2337/diacare.25.9.1529,12196422
True," The study meets all the inclusion criteria as it is a good quality study on adults with type 2 diabetes, using glimepiride as an intervention, and reports clinically relevant outcomes.",Glimepiride Improves Both First and Second Phases of Insulin Secretion in Type Diabetes,https://doi.org/10.2337/diacare.25.9.1607,12196435
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a randomized controlled trial, it involves adults with type 2 diabetes, and it examines the effect of a sulfonylurea (gliclazide) on clinically relevant outcomes.",Gliclazide improves antioxidant status and nitric oxidemediated vasodilation in Type diabetes,https://doi.org/10.1046/j.1464-5491.2002.00762.x,12207812
True," The study meets the inclusion criteria as it is a survey of adults with type 2 diabetes who received repaglinide treatment, and it reports on clinically relevant outcomes such as patient satisfaction and perceived glucose control.",Patient Perceptions of Prandial Oral Therapy for Type Diabetes,https://doi.org/10.1177/014572170102700507,12212016
True," The study meets all the inclusion criteria as it is a fair quality study involving adults with type 2 diabetes, examining the tablet-breaking ability of different formulations of glyburide, a sulfonylurea, in an outpatient setting.",TabletBreaking Ability of Older Persons With Type Diabetes Mellitus,https://doi.org/10.1177/014572170102700408,12212341
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial comparing the effects of repaglinide and metformin in combination with bedtime NPH insulin in patients with type 2 diabetes, and it reports on clinically relevant outcomes such as glycemic control, weight gain, and diabetes treatment satisfaction.",Repaglinide Versus Metformin in Combination With Bedtime NPH Insulin in Patients With Type Diabetes Established on InsulinMetformin Combination Therapy,https://doi.org/10.2337/diacare.25.10.1685,12351462
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",A Diabetes Outcome Progression Trial ADOPT,https://doi.org/10.2337/diacare.25.10.1737,12351470
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the factors associated with switching from oral hypoglycaemic agents to insulin therapy in an outpatient setting.",Factors associated with switching from oral hypoglycaemic agents to insulin therapy,nan,12365467
False," The study does not meet the inclusion criteria for intervention as it involves metformin, not sulfonylureas or short-acting secretagogues.",Discontinuation of metformin in type diabetes patients treated with insulin,nan,12365468
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but the study is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it assesses clinically relevant outcomes.",Durability of efficacy and longterm safety profile of glyburidemetformin tablets in patients with type diabetes mellitus an openlabel extension study,https://doi.org/10.1016/s0149-2918(02)80044-3,12380632
True," The study appears to be a systematic review of randomized controlled trials, which meets the inclusion criteria for study design.",Quality of Care in Diabetes Understanding the Guidelines,https://doi.org/10.1097/00000441-200210000-00006,12385492
True," The study meets all the inclusion criteria as it is a retrospective cohort analysis of adults with type 2 diabetes, comparing the effectiveness of a physician-pharmacist collaborative drug therapy management clinic with standard care, and reports on clinically relevant outcomes.",A Retrospective Cohort Analysis of the Clinical Effectiveness of a PhysicianPharmacist Collaborative Drug Therapy Management Diabetes Clinic,https://doi.org/10.1592/phco.22.15.1294.33476,12389879
False," The abstract does not contain original data, as it is a review of existing literature.",Oral Antihyperglycemic Agents During Pregnancy and Lactation,https://doi.org/10.2165/00128072-200204110-00007,12390047
False," The article does not contain original data, as it is a review of the history of troglitazone.",Troglitazone the discovery and development of a novel therapy for the treatment of Type diabetes mellitus,https://doi.org/10.1016/s0169-409x(02)00093-5,12393300
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it assesses clinically relevant outcomes.",A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients With Type Diabetes,https://doi.org/10.2337/diacare.25.11.2058,12401757
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes of different races, ages, and gender.",Glyburidemetformin combination product is safe and efficacious in patients with type diabetes failing sulphonylurea therapy,https://doi.org/10.1046/j.1463-1326.2002.00229.x,12406033
False, The article does not meet the inclusion criteria as it does not focus on the specified oral hypoglycemic drugs (sulfonylureas and short-acting secretagogues) and their effects on PAI in adults with type 2 diabetes.,Plasminogen Activator Inhibitor Physiologic Role Regulation and the Influence of Common Pharmacologic Agents,https://doi.org/10.1177/009127002762491271,12412817
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, and it investigates the effect of glyburide on QT dispersion in adults with type 2 diabetes.",Differential effect of glyburide glibenclamide and metformin on qt dispersion a potential adenosine triphosphate sensitive k channel effect,https://doi.org/10.1016/s0002-9149(02)02776-5,12423711
False, The article does not meet the inclusion criteria as it is a general overview of therapeutic options for diabetes management and does not focus on the specified interventions (sulfonylureas or short-acting secretagogues) or outcomes.,Therapeutic options for the management of type diabetes mellitus,nan,12437315
False," The abstract does not mention adults with type 2 diabetes, but rather gestational diabetes, which is a different condition.",The contentious nature of gestational diabetes diet insulin glyburide and metformin,https://doi.org/10.1517/14656566.3.11.1557,12437490
True," The study meets all the inclusion criteria as it is a fair quality study, includes adults with type 2 diabetes, uses a sulfonylurea as an intervention, and reports clinically relevant outcomes.",Combinationtherapy with bedtime nph insulin and sulphonylureas gives similar glycaemic control but lower weight gain than insulin twice daily in patients with type diabetes,nan,12442064
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",Pharmacokinetics and Pharmacodynamics of GlyburideMetformin Tablets Glucovance versus Equivalent Doses of Glyburide and Metformin in Patients with Type Diabetes,https://doi.org/10.2165/00003088-200241150-00004,12452739
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, and it investigates the effect of glipizide GITS and metformin on clinically relevant outcomes in adults with type 2 diabetes.",Effect of Combination Glipizide GITSMetformin on Fibrinolytic and Metabolic Parameters in Poorly Controlled Type Diabetic Subjects,https://doi.org/10.2337/diacare.25.12.2123,12453948
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, and it investigates the effects of nateglinide on insulin secretion and glucose control in a prediabetic population.",Nateglinide Improves Early Insulin Secretion and Controls Postprandial Glucose Excursions in a Prediabetic Population,https://doi.org/10.2337/diacare.25.12.2141,12453951
False," The article does not contain original data, as it is a discussion of the pathophysiologic knowledge and therapeutic guidelines for type 2 diabetes, without presenting any new research findings.",Oral anti diabetic polychemotherapy in type diabetes mellitus,nan,12461471
False," The study does not meet the inclusion criteria as it is focused on the development of a method for high-throughput inhibition screening of human cytochrome P enzymes, not on the effects of sulfonylureas or short-acting secretagogues in adults with type 2 diabetes.",Highthroughput inhibition screening of major human cytochrome P enzymes using an in vitro cocktail and liquid chromatographytandem mass spectrometry,https://doi.org/10.1016/s0731-7085(02)00480-6,12467917
False," The article does not contain original data, as it is a non-systematic review.",Rosiglitazone and pioglitazone new preparations Two new oral antidiabetics both poorly assessed,nan,12469695
False," The study does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, and it does not focus on the specified interventions (sulfonylureas or short-acting secretagogues).",DOES TYPE DIABETES MELLITUS DELAY RENAL FAILURE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE,https://doi.org/10.1081/jdi-120015682,12472202
True," The study meets the inclusion criteria as it is a fair quality study that includes adults with type 2 diabetes, uses sulfonylureas as an intervention, and reports clinically relevant outcomes.",Aspects of antihyperglycemic oral bitherapy in cases of non insulindependent diabetes in Dakar,nan,12473527
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with no specific mention of diabetes, and examines the effect of sulfonylurea (glibenclamide and gliclazide) on vascular KATP channels in healthy humans.",Effects of inhibition of ATPsensitive potassium channels on metabolic vasodilation in the human forearm,https://doi.org/10.1042/cs1040039,12519086
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with diabetes of different ethnicities, and examines the pharmacokinetics of a short-acting secretagogue (repaglinide).",Pharmacokinetics of Repaglinide in Healthy Caucasian and Japanese Subjects,https://doi.org/10.1177/0091270002239702,12520624
False," The study does not meet the inclusion criteria as it is focused on the pharmacokinetics of tolbutamide, flurbiprofen, and losartan as probes of CYPC activity, not on the effects of sulfonylureas or short-acting secretagogues in adults with type 2 diabetes.",Tolbutamide Flurbiprofen and Losartan as Probes of CYPC Activity in Humans,https://doi.org/10.1177/0091270002239710,12520632
False," The article does not meet the inclusion criteria as it does not mention the intervention of sulfonylureas or short-acting secretagogues, which are specified in the inclusion criteria.",The Angiotensinreceptor Blockers From Antihypertensives to Cardiovascular Allround Medications in Years,https://doi.org/10.1080/080370502321095285,12523675
False," The study does not meet the inclusion criteria as it is a basic research study on the molecular basis of Kir channel inhibition by adenine nucleotides, not a clinical study on the effects of sulfonylureas in adults with type 2 diabetes.",Molecular Basis for Kir Channel Inhibition by Adenine Nucleotides,https://doi.org/10.1016/s0006-3495(03)74847-4,12524280
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, investigating the effect of two specific oral hypoglycemic drugs (acarbose and glibenclamide) on insulin sensitivity in adults with type 2 diabetes.",Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type diabetic patients,https://doi.org/10.1046/j.1463-1326.2003.00239.x,12542723
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glimepiride) as the intervention, and reports clinically relevant outcomes.",Plasma Adiponectin Plays an Important Role in Improving Insulin Resistance With Glimepiride in Elderly Type Diabetic Subjects,https://doi.org/10.2337/diacare.26.2.285,12547850
False," The abstract does not mention the use of sulfonylureas or short-acting secretagogues as the intervention, which is a specified inclusion criterion.",Pharmacotherapy of Diabetes Mellitus Implications for the Prevention and Treatment of Cardiovascular Disease,https://doi.org/10.1097/01.hdx.0000050411.62103.f5,12549986
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but the study is a randomized controlled trial, it includes adults with type 2 diabetes, and it assesses clinically relevant outcomes.",Multifactorial Intervention and Cardiovascular Disease in Patients with Type Diabetes,https://doi.org/10.1056/nejmoa021778,12556541
True," The abstract indicates that the paper is a systematic review or double-blind, randomized controlled trial, which meets the inclusion criteria.",Treatment of Diabetes Mellitus in Older People Oral Therapy Options,https://doi.org/10.1046/j.1532-5415.2003.51070.x,12558728
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial comparing rosiglitazone with glyburide in patients with type II diabetes, and it reports on clinically relevant outcomes.",Rosiglitazone reduces urinary albumin excretion in type II diabetes,https://doi.org/10.1038/sj.jhh.1001444,12571611
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the effect of a sulfonylurea (gliclazide) in a systematic manner.",Population PKPD modelling of the longterm hypoglycaemic effect of gliclazide given as a onceaday modified release MR formulation,https://doi.org/10.1046/j.1365-2125.2003.01751.x,12580986
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, uses glyburide as an intervention, and examines clinically relevant outcomes.",Beneficial Effects of a GlyburideMetformin Combination Preparation in Type Diabetes Mellitus,https://doi.org/10.1097/00000441-200302000-00003,12589230
False," The study does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, but rather a discussion of existing evidence.",Treatment of type diabetes inadequate assessment of oral antidiabetic combinations,nan,12602406
False, The study does not meet the inclusion criteria as it is a case report and does not provide original data from a systematic review or a randomized controlled trial.,Use of Octreotide to Treat Prolonged Sulfonylureainduced Hypoglycemia in a Patient with Chronic Renal Failure,https://doi.org/10.1177/039139880302600113,12602474
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses repaglinide as an intervention, and reports clinically relevant outcomes.",Safety and Efficacy of Repaglinide in Type Diabetic Patients With and Without Impaired Renal Function,https://doi.org/10.2337/diacare.26.3.886,12610054
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a relevant intervention (nateglinide), and is conducted in an outpatient setting.",Pharmacokinetics of Nateglinide in Renally Impaired Diabetic Patients,https://doi.org/10.1177/0091270002239825,12616669
False," The paper does not contain original data, as it is a review of existing knowledge on the topic.",The relative contributions of insulin resistance and betacell dysfunction to the pathophysiology of Type diabetes,https://doi.org/10.1007/s00125-002-1009-0,12637977
False," The article does not meet the inclusion criteria as it is a review summarizing existing data rather than a systematic review or double-blind, randomized controlled trial.",MaternalFetal Transport of Hypoglycaemic Drugs,https://doi.org/10.2165/00003088-200342040-00001,12648023
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it reports original data on the effect of oral magnesium supplementation in type 2 diabetic patients.",Oral Magnesium Supplementation Improves Insulin Sensitivity and Metabolic Control in Type Diabetic Subjects,https://doi.org/10.2337/diacare.26.4.1147,12663588
False," The abstract does not mention the specific oral hypoglycemic drugs used in the study, which does not match the inclusion criteria.",Oral hypoglycaemic agent failure,nan,12674170
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of a short-acting secretagogue (nateglinide) in adults with type 2 diabetes, and reports on clinically relevant outcomes.",Efficacy and safety of nateglinide in the treatment of type II diabetes mellitus,nan,12674176
False," The abstract does not mention any specific intervention by sulfonylureas or short-acting secretagogues, which is a required inclusion criterion.",Obesity and Type Diabetes in the Elderly,https://doi.org/10.1159/000069176,12679603
False," The article is a critical review of insulin analogues, not a systematic review or double-blind, randomized controlled trial.",Insulin analogues A critical review,nan,12685221
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it investigates the effect of a specific sulfonylurea (glibenclamide) on clinically relevant outcomes in patients with type 2 diabetes.",Slowly Progressing Type Diabetes Persistence of Islet Cell Autoantibodies is Related to Glibenclamide Treatment,https://doi.org/10.1080/0891693021000050574,12685875
True," The study meets the inclusion criteria as it is a fair quality study of adults with type 2 diabetes of different races, ages, and gender, and it evaluates the effects of a short-acting secretagogue (nateglinide).",Evaluation of the Effects of Nateglinide on Postprandial Glycemia in Patients with Type Diabetes mellitus A Multicenter Multinational NonRandomized NonControlled Latin American Study,https://doi.org/10.1159/000069534,12711836
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",Addition of Rosiglitazone to Existing Sulfonylurea Treatment in Chinese Patients with Type Diabetes and Exposure to Hepatitis B or C,https://doi.org/10.1089/152091503763816445,12725705
False," The article is a review of the literature rather than a systematic review or double-blind, randomized controlled trial, and it does not contain original data.",Chromium as Adjunctive Treatment for Type Diabetes,https://doi.org/10.1345/aph.1c304,12773078
False, The abstract does not mention the intervention being either by sulfonylureas or short-acting secretagogues.,NN Novo Nordisk,nan,12789615
True," The study meets all the inclusion criteria as it is a systematic review of the effects of oral antidiabetic drugs on cardiovascular complications in type 2 diabetes patients, and it includes clinically relevant outcomes such as progression of microvascular disease and all-cause mortality.",Oral antidiabetic therapy and cardiovascular complications theoretical problem or clinical evidence,nan,12795025
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, assessing clinically relevant outcomes such as quality of life and treatment satisfaction in adults with type 2 diabetes.",The effect of prandial glucose regulation with repaglinide on treatment satisfaction wellbeing and health status in patients with pharmacotherapy nave Type diabetes a placebocontrolled multicentre study,https://doi.org/10.1023/a:1023495106160,12797714
False, The article does not contain original data as it appears to be a review of existing knowledge on thiazolidinediones.,Thiazolidinediones in diabetes current status and future outlook,nan,12808879
False," The abstract does not contain original data, as it appears to be a news article or press release about a company's development of a new drug, rather than a research study.",NN Novo Nordisk,nan,12808887
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, investigating the efficacy and safety of glimepiride combined with different types of insulin in patients with type 2 diabetes, and reports clinically relevant outcomes.",Glimepiride Combined with Morning Insulin Glargine Bedtime Neutral Protamine Hagedorn Insulin or Bedtime Insulin Glargine in Patients with Type Diabetes,https://doi.org/10.7326/0003-4819-138-12-200306170-00006,12809451
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial (crossover design) in adults with type 2 diabetes, comparing the effects of two sulfonylureas, and reports clinically relevant outcomes.",Comparison of the micro and macrovascular effects of glimepiride and gliclazide in metformintreated patients with Type diabetes a doubleblind crossover study,https://doi.org/10.1046/j.1365-2125.2003.01781.x,12814458
True," The study meets the inclusion criteria as it is a systematic review of the pharmacokinetics and safety of repaglinide in the presence of drugs interacting with CYP3A, which is a good quality study, and it involves adults with diabetes.",Influence of Drugs Interacting with CYPA on the Pharmacokinetics Pharmacodynamics and Safety of the Prandial Glucose Regulator Repaglinide,https://doi.org/10.1177/0091270003253704,12817528
True," The study meets all the inclusion criteria as it is a fair quality study on glimepiride, an oral antidiabetic agent, in adults with type 2 diabetes, and it reports on clinically relevant outcomes.",Glimepiridean oral antidiabetic agent,nan,12822388
False," The study is a case report, which does not contain original data.",Case Report Inadvertent Sulfonylurea Overdosage and Hypoglycemia in an Elderly Woman Failure of Serum Hypoglycemia Screening,https://doi.org/10.1089/152091503765691956,12828829
False, The article is a non-systematic review and does not contain original data.,Analysis A Flaw in the Use of Sulfonylurea Screening to Diagnose Sulfonylurea Overdosages,https://doi.org/10.1089/152091503765691965,12828830
True," The study meets all the inclusion criteria as it is a review of glimepiride in type 2 diabetes, includes good and fair quality studies, and focuses on clinically relevant outcomes.",Glimerpiride in type diabetes mellitus A review of the worldwide therapeutic experience,https://doi.org/10.1016/s0149-2918(03)80109-1,12852703
True," The study meets all the inclusion criteria as it is a systematic review of first-line oral antihyperglycaemic medications in type 2 diabetes, includes adults of different races, ages, and gender, and reports on clinically relevant outcomes.",Economic Model of FirstLine Drug Strategies to Achieve Recommended Glycaemic Control in Newly Diagnosed Type Diabetes Mellitus,https://doi.org/10.2165/00019053-200321110-00005,12859222
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, examining the effect of a specific intervention (exenatide synthetic exendin additive) on clinically relevant outcomes in adults with type 2 diabetes.",Effect on Glycemic Control of Exenatide Synthetic Exendin Additive to Existing Metformin andor Sulfonylurea Treatment in Patients With Type Diabetes,https://doi.org/10.2337/diacare.26.8.2370,12882864
False," The article is a case report and literature review, not a systematic review or double-blind, randomized controlled trial.",Possible Heart Failure Exacerbation Associated with Rosiglitazone Case Report and Literature Review,https://doi.org/10.1592/phco.23.7.945.32721,12885108
True," The study meets all the inclusion criteria as it is a systematic review of a new antidiabetic agent, includes adults with type 2 diabetes, and focuses on clinically relevant outcomes.",Nateglinide Starlix update on a new antidiabetic agent,nan,12918894
False," The study does not meet the inclusion criteria as it is focused on the pharmacokinetics of nateglinide in patients with renal failure, and does not involve the use of sulfonylureas or short-acting secretagogues as interventions.",Pharmacokinetics of nateglinide and its metabolites in subjects with type diabetes mellitus and renal failure,https://doi.org/10.5414/cnp60090,12940610
True," The study meets all the inclusion criteria as it is a systematic review is not explicitly stated but it is a comparison of different treatments, it is a double-blind, randomized controlled trial, and it includes clinically relevant outcomes.",Lispro insulin and metformin versus other combination in the diabetes mellitus type management after secondary oral antidiabetic drug failure,nan,12974145
True," The study meets all the inclusion criteria as it is a systematic review of pharmacological regulation of mealtime glucose excursions in type diabetics, specifically focusing on repaglinide and nateglinide, and includes clinically relevant outcomes.",Cardiovascular risk in type diabetics and pharmacological regulation of mealtime glucose excursions,https://doi.org/10.1016/s1262-3636(07)70044-7,14526261
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a retrospective cohort study which is not excluded, it includes adults with type 2 diabetes, and it evaluates clinically relevant outcomes such as glycemic control.",Improvements in Glycemic Control in Type Diabetes Patients Switched From Sulfonylurea Coadministered With Metformin to GlyburideMetformin Tablets,https://doi.org/10.18553/jmcp.2003.9.3.256,14613469
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glipizide) as the intervention, and is a double-blind, randomized controlled trial in an outpatient setting.",Pharmacokinetics and Pharmacodynamics of Glipizide After OnceDaily and Divided Doses,nan,7479199
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glyburide as an intervention, and reports clinically relevant outcomes.",Polymorphonuclear Leukocytes in NonInsulindependent Diabetes Mellitus Abnormalities in Metabolism and Function,https://doi.org/10.7326/0003-4819-123-12-199512150-00004,7486486
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",Treatment of Hypercholesterolemia in NIDDM With Policosanol,https://doi.org/10.2337/diacare.18.3.393,7555484
True," The study meets the inclusion criteria as it is a double-blind controlled trial involving adults with type 2 diabetes, comparing the efficacy of miglitol and glibenclamide, and reports clinically relevant outcomes such as HbAc levels and fasting glycaemia.",Comparison of miglitol and glibenclamide in diettreated type diabetic patients,nan,7556806
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it examines clinically relevant outcomes.",Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes VA CSDM Results of the feasibility trial,https://doi.org/10.2337/diacare.18.8.1113,7587846
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it examines clinically relevant outcomes.",Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure,https://doi.org/10.2337/diacare.18.8.1183,7587856
True," The study meets all the inclusion criteria as it is a fair quality study involving adults with type 2 diabetes, using a sulfonylurea (glibenclamide or tolbutamide) as the intervention, and reports clinically relevant outcomes.",Effect of an Glucosidase Inhibitor Combined with Sulphonylurea Treatment on Glucose Metabolism in Patients with NonInsulinDependent Diabetes Mellitus,https://doi.org/10.1177/030006059502300408,7589771
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses sulfonylureas as an intervention, and reports clinically relevant outcomes.",UK prospective diabetes study Overview of years therapy of type II diabetes a progressive disease UK Prospective Diabetes Study Group,https://doi.org/10.2337/diabetes.44.11.1249,7589820
True," The study contains original data and is a systematic review of metformin's effects on type 2 diabetes, meeting the inclusion criteria for a review of studies on this topic.",Metformin,https://doi.org/10.2165/00003495-199549050-00007,7601013
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",Efficacy of Metformin in Patients with NonInsulinDependent Diabetes Mellitus,https://doi.org/10.1056/nejm199508313330902,7623902
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses sulfonylurea therapy, and is a crossover trial in an outpatient setting.",Energy Expenditure in Type Diabetic Patients on Metformin and Sulphonylurea Therapy,https://doi.org/10.1111/j.1464-5491.1995.tb00503.x,7648802
True," The study meets the inclusion criteria as it is a double-blind, randomized controlled trial (specifically a crossover study) in an outpatient setting, examining the effect of orlistat on the pharmacokinetics and pharmacodynamics of glyburide in healthy volunteers.",The Influence of Orlistat on the Pharmacokinetics and Pharmacodynamics of Glyburide in Healthy Volunteers,https://doi.org/10.1002/j.1552-4604.1995.tb04098.x,7657854
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, uses glipizide as an intervention, and reports on clinically relevant outcomes.",Insulin versus glipizide treatment in patients with noninsulindependent diabetes mellitusEffects on blood pressure and glucose tolerance,https://doi.org/10.1016/0895-7061(95)00052-q,7662219
True," The study meets the inclusion criteria as it is a systematic review of studies on lipid and lipoprotein abnormalities in patients with diabetes mellitus, and it discusses the risks and benefits of marketed pharmacologic therapies.",Dyslipidemias in Patients With Diabetes Mellitus Classification and Risks and Benefits of Therapy,nan,7667166
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glipizide as an intervention, and reports clinically relevant outcomes.",Effect of insulinglipizide combination on skeletal muscle capillary basement membrane width in diabetic patients,nan,7697692
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of glipizide, a sulfonylurea, in adults with type 2 diabetes, and reports clinically relevant outcomes.",Prolongation of NearNormoglycemic Remission in Black NIDDM Subjects With Chronic LowDose Sulfonylurea Treatment,https://doi.org/10.2337/diab.44.4.466,7698517
True," The study meets all the inclusion criteria as it is a good quality study examining insulin sensitivity and glucose disposal in black and white Americans at risk for type 2 diabetes, and it reports original data.",Minimal model analyses of insulin sensitivity and glucosedependent glucose disposal in black and white Americans a study of persons at risk for type diabetes,https://doi.org/10.1111/j.1365-2362.1994.tb02029.x,7705380
False," The study does not meet the inclusion criteria as it does not involve adults with type 2 diabetes, but rather normal subjects.",Acute effects of glyburide on the regulation of peripheral blood flow in normal humans,https://doi.org/10.1016/0014-2999(94)00732-m,7768272
True," The study meets all the inclusion criteria as it is a good quality study of adults with type 2 diabetes treated with chlorpropamide, a sulfonylurea, and includes clinically relevant outcomes such as glucose control and quality of life.",Response of insulin and Cpeptide to a mixed meal in noninsulindependent diabetics treated with insulin and chlorpropamide,nan,7777712
True," The study meets the inclusion criteria as it is a fair quality study that investigates the effect of insulin treatment on serum lipoprotein(a) in noninsulin-dependent diabetes patients, which is a relevant outcome for the review.",Effect of insulin treatment on serum lipoproteina in noninsulindependent diabetes,https://doi.org/10.1111/j.1365-2362.1995.tb01548.x,7781667
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea as an intervention, and reports clinically relevant outcomes.",Effect of Metformin on Postprandial Lipemia in Patients With Fairly to Poorly Controlled NIDDM,https://doi.org/10.2337/diacare.17.10.1093,7821127
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the effect of short-term blood glucose normalization on visual evoked potential latencies.",Improved Visual Evoked Potential Latencies In Poorly Controlled Diabetic Patients After ShortTerm Strict Metabolic Control,https://doi.org/10.2337/diacare.17.10.1141,7821133
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glyburide as the intervention, and reports clinically relevant outcomes.",Comparison of Pharmacokinetics and Pharmacodynamics of Short and LongTerm Glyburide Therapy in NIDDM,https://doi.org/10.2337/diacare.17.11.1300,7821171
True," The study meets all the inclusion criteria as it is a retrospective study examining the effect of rehabilitation therapy on diabetic control in diabetic stroke patients, and it reports original data.",Control of Diabetes during Rehabilitation for Diabetic Stroke,https://doi.org/10.1620/tjem.173.399,7825173
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (chlorpropamide) as an intervention, and reports clinically relevant outcomes.",United Kingdom prospective diabetes study UKPDS relative efficacy of randomly allocated diet sulphonylurea insulin or metformin in patients with newly diagnosed noninsulin dependent diabetes followed for three years,https://doi.org/10.1136/bmj.310.6972.83,7833731
True," The study meets the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the effect of a sulfonylurea (glipizide) in an outpatient setting.",Lack of Interaction Between Glipizide and CoTrimoxazole,https://doi.org/10.1002/j.1552-4604.1994.tb01972.x,7836551
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial comparing the effects of metformin and glipizide in adults with type 2 diabetes, and reports clinically relevant outcomes.",One year comparative trial of metformin and glipizide in type diabetes mellitus,nan,7843470
False," The article does not contain original data, as it is a review of existing knowledge on the tolerability profiles of oral antidiabetic agents.",Comparative Tolerability Profiles of Oral Antidiabetic Agents,https://doi.org/10.2165/00002018-199411040-00002,7848543
False, The study does not meet the inclusion criteria as it does not involve an intervention by sulfonylureas or short-acting secretagogues.,Ethnic Differences in Secretion Sensitivity and Hepatic Extraction of Insulin in Black and White Americans,https://doi.org/10.1111/j.1464-5491.1994.tb00349.x,7851069
True," The study meets all the inclusion criteria as it is a fair quality study, includes adults with type 2 diabetes, uses a sulfonylurea (glibenclamide) as the intervention, and reports clinically relevant outcomes such as mortality.",Effects of glibenclamide on ventricular fibrillation in noninsulindependent diabetics with acute myocardial infarction,nan,7858767
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in adults with type 2 diabetes, comparing the efficacy of glipizide with or without sulfonylurea therapy.",Bedtime InsulinDaytime Glipizide Effective Therapy for Sulfonylurea Failures in NIDDM,https://doi.org/10.2337/diab.44.2.165,7859936
False, The article does not meet the inclusion criteria as it is a review paper and does not contain original data.,Reevaluation of a biguanide metformin mechanism of action and tolerability,https://doi.org/10.1016/1043-6618(94)80104-5,7862618
True," The study meets all the inclusion criteria as it is a good quality study involving healthy volunteers, uses a sulfonylurea (glyburide) as the intervention, and reports original data.",LowDose Oral Glyburide Reduces Fasting Blood Glucose by Decreasing Hepatic Glucose Production in Healthy Volunteers Without Increasing Carbohydrate Oxidation,https://doi.org/10.1097/00000441-199503000-00003,7879817
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glipizide) as the intervention, and reports clinically relevant outcomes.",Comparative Efficacy of a OnceDaily ControlledRelease Formulation of Glipizide and ImmediateRelease Glipizide in Patients With NIDDM,https://doi.org/10.2337/diacare.17.12.1460,7882817
True," The study meets the inclusion criteria as it is a fair quality study that investigates the relation of abnormal composition of lipoproteins to HbAc levels in noninsulin dependent diabetes, and it involves the use of a specific oral hypoglycemic agent (glibenclamide).",Relation of abnormal composition of lipoproteins to HbAc levels in noninsulin dependent diabetes,nan,7886271
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, includes adults with type 2 diabetes, and reports clinically relevant outcomes.",Antihyperglycaemic Efficacy Response Prediction and DoseResponse Relations of Treatment with Metformin and Sulphonylurea Alone and in Primary Combination,https://doi.org/10.1111/j.1464-5491.1994.tb00253.x,7895460
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial comparing two sulphonylureas in elderly patients with type 2 diabetes, and it reports on clinically relevant outcomes such as hypoglycemic reactions and insulin sensitivity.",Glibenclamide vs Gliclazide in Type Diabetes of the Elderly,https://doi.org/10.1111/j.1464-5491.1994.tb00256.x,7895463
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it involves the use of glyburide, a sulfonylurea, in the treatment of type 2 diabetes.",A comparative study of insulin and glyburide versus glyburide or insulin in the chronic control of patients with type diabetes,nan,7926425
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glyburide as the intervention, and is a double-blind, randomized controlled trial in an outpatient setting.",Bedtime Dosing of Glyburide and the Treatment of Type II Diabetes Mellitus,https://doi.org/10.1097/00000441-199430840-00004,7942982
False," The study does not meet the inclusion criteria as it involves healthy subjects, not adults with type 2 diabetes.",Comparative doserelated timeaction profiles of glibenclamide and a new nonsulphonylurea drug AGEE ZW during euglycaemic clamp in healthy subjects,https://doi.org/10.1007/bf00417695,7958542
True," The study meets the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, assessing the hypoglycemic effect of glyburide glibenclamide metabolites in healthy subjects.",Hypoglycemic Activity of Glyburide Glibenclamide Metabolites in Humans,https://doi.org/10.2337/diacare.17.9.1026,7988301
True, The study meets all the inclusion criteria as it is a systematic comparison of glibenclamide absorption in normoglycaemic and hyperglycaemic states in patients with noninsulindependent diabetes mellitus.,The effect of hyperglycaemia on the absorption of glibenclamide in patients with noninsulindependent diabetes mellitus,https://doi.org/10.1007/bf00193478,7988624
True," The study meets all the inclusion criteria as it is a good quality study examining the effect of glipizide treatment on postprandial lipaemia in patients with NIDDM, and it reports original data.",Effect of glipizide treatment on postprandial lipaemia in patients with NIDDM,https://doi.org/10.1007/bf00404335,7988780
False," The study does not meet the inclusion criteria as it is focused on type 1 diabetic patients, not type 2, and the intervention is not a sulfonylurea or short-acting secretagogue.",Metabolic clearance rate of insulin in type diabetic patients treated with combined insulin and sulfonylurea therapy,nan,7991936
False, The study does not meet the inclusion criteria as it is an in vitro study and does not involve human subjects with type 2 diabetes.,Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages,https://doi.org/10.1016/0021-9150(94)90045-0,8003091
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes treated with sulfonylureas.",Effectiveness and tolerance of longterm acarbose therapy in diabetic patients with threatened secondary failure of sulfonylurea drug treatment,nan,8015532
True," The study meets the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, and it investigates the effects of felodipine on hypertensive type II diabetic males on sulfonylurea treatment.",Shortterm effects of felodipine in hypertensive type II diabetic males on sulfonylurea treatment,https://doi.org/10.1111/j.1365-2796.1994.tb01119.x,8021573
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but the study is a randomized controlled trial, it involves adults with type 1 diabetes, and it examines the effect of glipizide in combination with intensive insulin treatment.",The Use of Glipizide Combined with Intensive Insulin Treatment for the Induction of Remissions in New Onset Adult Type I Diabetes,https://doi.org/10.3109/08916939309014647,8025207
False," The study does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, and it does not include clinically relevant outcomes such as progression or occurrence of microvascular disease, other complications of diabetes, quality of life, and all-cause mortality.",Effect of Sulphonylurea Therapy on Plasma Insulin Intact and Split Proinsulin in Subjects with Type Diabetes Mellitus,https://doi.org/10.1111/j.1464-5491.1994.tb00274.x,8033529
True," The study meets all the inclusion criteria as it is a good quality study on adults with type 2 diabetes, examining the effects of glipizide, a sulfonylurea, on glucose metabolism and muscle content of the insulin-regulatable glucose transporter GLUT and glycogen synthase activity.",Effects of glipizide on glucose metabolism and muscle content of the insulinregulatable glucose transporter GLUT and glycogen synthase activity during hyperglycaemia in type diabetic patients,https://doi.org/10.1007/bf00580757,8043894
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, and it investigates the effect of a sulfonylurea (glibenclamide) on ischemic preconditioning in humans.",Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide a selective ATPsensitive K channel blocker,https://doi.org/10.1161/01.cir.90.2.700,8044938
True," The study meets all the inclusion criteria as it is a good quality study involving adults with type 2 diabetes treated with sulfonylurea derivatives in an outpatient setting, and it reports original data.",Alcohol tolerance in patients with noninsulindependent type diabetes treated with sulphonylurea derivatives,nan,8053971
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes treated with sulfonylureas.",Metabolic effects of metformin addition to chronic glibenclamide treatment in type diabetes,nan,8056129
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses sulfonylurea as the intervention, is a double-blind, randomized controlled trial in an outpatient setting, and reports clinically relevant outcomes.",A longterm randomized comparative study of insulin versus sulfonylurea therapy in type diabetes,https://doi.org/10.1111/j.1365-2796.1994.tb00801.x,8077888
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes treated with sulfonylureas.",Efficacy of Week Monotnerapy With Acarbose Glibenclamide or Placebo in NIDDM Patients The Essen Study,https://doi.org/10.2337/diacare.17.6.561,8082525
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial comparing two sulfonylureas (glyburide and glipizide) in elderly patients with type 2 diabetes, and reports on clinically relevant outcomes.",Diabetes control in the elderly a randomized comparative study of glyburide versus glipizide in noninsulindependent diabetes mellitus,nan,8111800
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (gliclazide) as the intervention, and reports clinically relevant outcomes.",Efficacy and safety of gliclazide in the treatment of noninsulindependent diabetes mellitus a Canadian multicenter study,nan,8111803
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes treated with sulfonylureas.",Effects of the Carbohydrase Inhibitor Miglitol in SulfonylureaTreated NIDDM Patients,https://doi.org/10.2337/diacare.17.1.20,8112185
True," The study meets all the inclusion criteria as it is a fair quality study involving adults with type 2 diabetes, uses a relevant intervention (an alpha-glucosidase inhibitor), and reports clinically relevant outcomes.",Effect of an Glucosidase Inhibitor on Intestinal Fermentation and Faecal Lipids in Diabetic Patients,https://doi.org/10.1177/030006059302100504,8112483
False," The article does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, and it does not focus on the specified interventions (sulfonylureas or short-acting secretagogues).",Management of diabetes in general practicecurrent requirements Oral antidiabetics and insulin therapy,nan,8200602
True," The study meets the inclusion criteria as it is a double-blind, randomized controlled trial that investigates the effectiveness of intermittent versus continuous sulphonylurea therapy in adults with type 2 diabetes.",Continuous versus Intermittent Sulphonylurea Therapy in NonInsulinDependent Diabetes Mellitus,https://doi.org/10.2165/00002018-199309040-00002,8260118
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of a sulfonylurea (glyburide) in adults with type 2 diabetes, and reports on clinically relevant outcomes.",Efficacy and safety of reformulated micronized glyburide tablets in patients with noninsulindependent diabetes mellitus a multicenter doubleblind randomized trial,nan,8269445
True," The study meets all the inclusion criteria as it is a good quality study on adults with type 2 diabetes, specifically examining the effect of gliclazide, a sulfonylurea, on plasma lipids and pancreatic beta cell function.",Effect of gliclazide on plasma lipids and pancreatic beta cell function in noninsulindependent diabetes mellitus,nan,8313208
True," The study meets all the inclusion criteria as it is a systematic review of the prevention of complications in NIDDM, includes adults with type 2 diabetes of different races, ages, and gender, and focuses on the use of sulfonylureas and short-acting secretagogues.",Prevention of Complications in NonInsulinDependent Diabetes Mellitus NIDDM,https://doi.org/10.2165/00003495-199550020-00006,8521759
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it includes clinically relevant outcomes such as progression or occurrence of microvascular disease, quality of life, and all-cause mortality.",Comparison between acarbose metformin and insulin treatment in type diabetic patients with secondary failure to sulfonylurea treatment,nan,8529760
True," The study meets all the inclusion criteria as it is a good quality randomized controlled trial of adults with type 2 diabetes, comparing the effects of sulfonylureas and short-acting secretagogues on clinically relevant outcomes.",United Kingdom Prospective Diabetes Study A Year Update of a Randomized Controlled Trial on the Effect of Improved Metabolic Control on Complications in NonInsulindependent Diabetes Mellitus,https://doi.org/10.7326/0003-4819-124-1_part_2-199601011-00011,8554206
False," The abstract does not mention the use of sulfonylureas or short-acting secretagogues as interventions, which are specified in the inclusion criteria.",Diet and Diabetes in the Elderly,https://doi.org/10.1016/s0749-0690(18)30260-x,8556690
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",Metabolic benefits deriving from chronic vitamin C supplementation in aged noninsulin dependent diabetics,https://doi.org/10.1080/07315724.1995.10718526,8568117
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, and examines the effect of sulfonylurea on the secretion of incretin hormones in response to glucose ingestion.",Response of truncated glucagonlike peptide and gastric inhibitory polypeptide to glucose ingestion in noninsulin dependent diabetes mellitus,https://doi.org/10.1007/bf00838486,8590785
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial involving adults with type 2 diabetes, comparing the efficacy of a traditional Chinese treatment with a sulfonylurea, and reports clinically relevant outcomes.",Randomized study of glibenclamide versus traditional Chinese treatment in type diabetic patients ChineseFrench Scientific Committee for the Study of Diabetes,nan,8593925
False," The study does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, and it does not focus on the specified oral hypoglycemic drugs.",Activity of superoxide dismutase in erythrocytes and leukocytes and levels of zinc and copper in blood of patients with diabetes Effect of diabetic treatment on examined parameters,nan,8596760
True," The study meets all the inclusion criteria as it is a systematic review of metformin as a treatment option for noninsulindependent diabetes mellitus, and it includes clinically relevant outcomes.",Metformin a new treatment option for noninsulindependent diabetes mellitus,nan,8656173
True," The study meets all the inclusion criteria as it is a prospective study on adults with type 2 diabetes, using sulfonylureas as an intervention, and reports original data.",Clinical usefulness of serum anhydroglucitol in monitoring glycaemic control,https://doi.org/10.1016/s0140-6736(96)90672-8,8684103
False, The study does not meet the inclusion criteria as it is a case report of a single patient and does not involve a systematic review or a randomized controlled trial.,Druginduced asterixis amplified by relative hypoglycemia,nan,8684512
True," The study meets all the inclusion criteria as it is a good quality study on adults with type 2 diabetes treated with a sulfonylurea, and it reports original data on clinically relevant outcomes.",Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylureainduced improvement of glycaemic control,https://doi.org/10.1007/bf00422374,8690177
True," The study meets all the inclusion criteria as it is a retrospective study assessing the efficacy of combination therapy with insulin and oral hypoglycemic agents in patients with type 2 diabetes, and it reports on clinically relevant outcomes.",Efficacy of combination therapy with insulin and oral hypoglycemic agents in patients with type II diabetes during a year period,https://doi.org/10.7556/jaoa.1996.96.6.346,8690621
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",Effects of Troglitazone A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy,https://doi.org/10.2337/diacare.19.2.151,8718436
True," The study meets all the inclusion criteria as it is a systematic review of metformin in noninsulindependent diabetes mellitus, includes adults with type 2 diabetes, and focuses on clinically relevant outcomes.",Metformin in noninsulindependent diabetes mellitus,nan,8726592
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it investigates the effects of a high-carbohydrate diet on adults with type 2 diabetes treated with hypoglycemic drugs.",Does a HighCarbohydrate Diet Have Different Effects in NIDDM Patients Treated With Diet Alone or Hypoglycemic Drugs,https://doi.org/10.2337/diacare.19.5.498,8732716
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it includes clinically relevant outcomes such as quality of life and progression of microvascular disease.",Daytime Glibenclamide and Bedtime NPH Insulin Compared to Intensive Insulin Treatment in Secondary Sulphonylurea Failure a Year Followup,https://doi.org/10.1002/(sici)1096-9136(199605)13:5<471::aid-dia103>3.0.co;2-t,8737030
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial (crossover design) in adults with type 2 diabetes, examining the effects of captopril on insulin sensitivity and circulating catecholamine levels.",Circulating catecholamines and metabolic effects of captopril in NIDDM patients,https://doi.org/10.2337/diacare.19.3.226,8742566
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, comparing the effects of acarbose and metformin as adjuvant therapies with a sulfonylurea agent in NIDDM patients.",A Comparison of Acarbose Versus Metformin as an Adjuvant Therapy in SulfonylureaTreated NIDDM Patients,https://doi.org/10.2337/diacare.19.3.252,8742572
True, The study meets the inclusion criteria as it is a good quality study examining the effect of glipizide on insulin metabolic clearance rate in healthy young subjects.,A novel mechanism of glipizide sulfonylurea action decreased metabolic clearance rate of insulin,https://doi.org/10.1007/bf00576262,8750768
False, The study does not meet the inclusion criteria as it is focused on healthy subjects rather than adults with type 2 diabetes.,The effect of physical exercise on glycemia on healthy subjects following administration of glimepiride,nan,8767351
True," The study meets the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial in an outpatient setting, and it investigates the effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects.",Effects of Aspirin and Ibuprofen on the Pharmacokinetics and Pharmacodynamics of Glyburide in Healthy Subjects,https://doi.org/10.1177/106002809603000103,8773160
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glimepiride) as the intervention, and reports clinically relevant outcomes.",A DoseResponse Study of Glimepiride in Patients With NIDDM Who Have Previously Received Sulfonylurea Agents,https://doi.org/10.2337/diacare.19.8.849,8842603
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glibenclamide) as an intervention, and reports clinically relevant outcomes.",GlucagonLike Peptide I Enhances the Insulinotropic Effect of Glibenclamide in NIDDM Patients and in the Perfused Rat Pancreas,https://doi.org/10.2337/diacare.19.8.857,8842604
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of glipizide, a sulfonylurea, in adults with NIDDM, and reports original data on clinically relevant outcomes.",The Effect of Glipizide Gastrointestinal Therapeutic System on Islet Cell Hormonal Responses to a Test Meal in NIDDM,https://doi.org/10.2337/diacare.19.8.883,8842609
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial (crossover design) in an outpatient setting, and it investigates the effect of adding glibenclamide to insulin in adults with type 2 diabetes.",More Uniform Diurnal Blood Glucose Control and a Reduction in Daily Insulin Dosage on Addition of Glibenclamide to Insulin in Type Diabetes Mellitus Role of Enhanced Insulin Sensitivity,https://doi.org/10.1111/j.1464-5491.1995.tb00390.x,8846678
False," The paper is a review of the pharmacokinetics of oral antidiabetic drugs, not a systematic review or double-blind, randomized controlled trial.",Pharmacokinetics of Oral Antihyperglycaemic Agents in Patients with Renal Insufficiency,https://doi.org/10.2165/00003088-199631020-00003,8853933
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, and it investigates the effect of a specific oral hypoglycemic drug (troglitazone) on insulin sensitivity and pancreatic cell function in adults with a high risk for NIDDM.",Effect of Troglitazone on Insulin Sensitivity and Pancreatic Cell Function in Women at High Risk for NIDDM,https://doi.org/10.2337/diab.45.11.1572,8866563
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, uses a second-generation sulfonylurea as the intervention, and is conducted in an outpatient setting.",The effect on metabolic control of secondgeneration sulfonylurea drugs in patients with NIDDM after secondary failure to firstgeneration agents,nan,8874372
True," The study meets the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the pharmacokinetics and pharmacodynamics of glipizide, a sulfonylurea, in an outpatient setting.",The Influence of Multiple Dosing and Age on the Pharmacokinetics and Pharmacodynamics of Glipizide in Patients with Type II Diabetes Mellitus,nan,8888072
True," The study meets all the inclusion criteria as it is a review of the safety and efficacy of acarbose in diabetes mellitus, includes adults with type 2 diabetes, and discusses clinically relevant outcomes.",A Review of the Safety and Efficacy of Acarbose in Diabetes Mellitus,nan,8888075
True," The study meets the inclusion criteria as it is a fair quality study involving adults with type 2 diabetes, using a sulfonylurea (tolbutamide) as the intervention, and reporting clinically relevant outcomes.",The Effect of a Very Low Dose of Tolbutamide Combined with an Glucosidase Inhibitor in NonInsulinDependent Diabetes Mellitus,https://doi.org/10.1177/030006059602400505,8895047
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it compares the effects of metformin with DNArecombinant insulin in patients with secondary failure to sulfonylureas.",Metformins Effects on Glucose and Lipid Metabolism in Patients with Secondary Failure to Sulfonylureas,https://doi.org/10.2337/diacare.19.11.1185,8908377
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of glimepiride in adults with type 2 diabetes, and it reports original data on clinically relevant outcomes.",Glimepiride a New OnceDaily Sulfonylurea A doubleblind placebocontrolled study of NIDDM patients,https://doi.org/10.2337/diacare.19.11.1194,8908379
True," The study meets all the inclusion criteria as it is a systematic review of clinical trials of acarbose in the treatment of diabetes mellitus, includes adults with type 2 diabetes, and reports on clinically relevant outcomes.",Acarbose Its Role in the Treatment of Diabetes Mellitus,https://doi.org/10.1177/106002809603001110,8913408
True," The study meets all the inclusion criteria as it is a systematic comparison of different insulin regimens in elderly patients with NIDDM, conducted in an outpatient setting, and reports clinically relevant outcomes such as glycemic control and quality of life.",Comparison of Different Insulin Regimens in Elderly Patients With NIDDM,https://doi.org/10.2337/diacare.19.12.1326,8941458
True," The study discusses new treatments for type 2 diabetes, including various oral medications such as glimepiride, repaglinide, and thiazolidinediones, which meet the inclusion criteria of being a systematic review or double-blind, randomized controlled trial in an outpatient setting.",New treatments for patients with type diabetes mellitus,https://doi.org/10.1136/pgmj.72.853.657,8944206
True," The study meets all the inclusion criteria as it is a prospective study evaluating the effects of sulfonylureas and short-acting secretagogues on patients with type 2 diabetes, and it includes clinically relevant outcomes such as progression of microvascular disease and all-cause mortality.",The UK Prospective Diabetes Study,https://doi.org/10.3109/07853899608999105,8949976
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glimepiride as the intervention, and reports clinically relevant outcomes.",Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment,https://doi.org/10.1007/s001250050624,8960852
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glibenclamide) as the intervention, and reports clinically relevant outcomes.",NIDDM a rapid progressive disease Results from a longterm randomised comparative study of insulin or sulphonylurea treatment,https://doi.org/10.1007/s001250050626,8960854
True," The study meets the inclusion criteria as it is a systematic comparison of two interventions (NPH and ultralente insulin) in patients with type 2 diabetes who have secondary failure to sulfonylurea, and it reports original data.",Comparative study of the efficiency of ultralente insulin and NPH insulin combined with sulfonylurea in type diabetes patients with secondary tolerance to sulfonylurea Possible selection criteria,nan,9026680
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, involves adults with type 2 diabetes, and examines the effect of a sulfonylurea (glyburide) with another medication (eprosartan).",Eprosartan an Angiotensin II Receptor Antagonist Does Not Affect the Pharmacodynamics of Glyburide in Patients with Type II Diabetes Mellitus,https://doi.org/10.1002/j.1552-4604.1997.tb04774.x,9055142
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, and examines the effects of a specific intervention (continuous subcutaneous insulin infusion) on clinically relevant outcomes.",Shortterm effects of continuous subcutaneous insulin infusion treatment on insulin secretion in noninsulindependent overweight patients with poor glycaemic control despite maximal oral antidiabetic treatment,nan,9059766
False," The study does not meet the inclusion criteria as it does not involve adults with type 2 diabetes, and the intervention is not a sulfonylurea or a short-acting secretagogue.",A Study of the Potential Effect of Sertraline on the Pharmacokinetics and Protein Binding of Tolbutamide,https://doi.org/10.2165/00003088-199700321-00005,9068933
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, compares insulin with oral hypoglycemic agents, and reports clinically relevant outcomes such as microvascular disease and other complications of diabetes.",Increased complications in noninsulindependent diabetic patients treated with insulin versus oral hypoglycemic agents a population study,nan,9069587
True," The study meets the inclusion criteria as it is a good quality study involving adults with type 2 diabetes, examining the interaction between rifampicin and glibenclamide, a sulfonylurea, in an outpatient setting.",Drug interaction rifampicin and glibenclamide,nan,9069698
False, The study does not meet the inclusion criteria as it is focused on MODY and does not involve the use of sulfonylureas or short-acting secretagogues as interventions.,Novel MODY Mutations in the Hepatocyte Nuclear Factor Gene Evidence for a Hyperexcitability of Pancreatic cells to Intravenous Secretagogues in a GlucoseTolerant Carrier of a PL Mutation,https://doi.org/10.2337/diab.46.4.726,9075819
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but the study is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it examines the effect of a sulfonylurea (glyburide) on clinically relevant outcomes.",Sulfonylurea Treatment Prevents Recurrence of Hyperglycemia in Obese AfricanAmerican Patients With a History of Hyperglycemic Crises,https://doi.org/10.2337/diacare.20.4.479,9096964
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, and examines the pharmacokinetics and pharmacodynamics of a sulfonylurea, gliquidone.",Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with noninsulindependent type diabetes mellitus,nan,9105542
True," The study meets all the inclusion criteria as it is a systematic review of the pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, and dosage and administration of metformin hydrochloride, and it is written in English.",Metformin hydrochloride An antihyperglycemic agent,https://doi.org/10.1093/ajhp/54.8.893,9114921
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, comparing the efficacy and safety of a sulfonylurea (glibenclamide) with an alpha-glucosidase inhibitor (miglitol) in adults with type 2 diabetes.",The Efficacy and Safety of Miglitol Therapy Compared With Glibenclamide in Patients With NIDDM Inadequately Controlled by Diet Alone,https://doi.org/10.2337/diacare.20.5.687,9135927
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial (crossover design) in an outpatient setting, comparing the effects of two oral hypoglycemic drugs (glibenclamide and metformin) on adults with type 2 diabetes, and reports clinically relevant outcomes.",Comparative Effects of Glibenclamide and Metformin on Ambulatory Blood Pressure and Cardiovascular Reactivity in NIDDM,https://doi.org/10.2337/diacare.20.5.692,9135928
True," The study meets all the inclusion criteria as it is a systematic review of the management of NIDDM in the elderly, includes adults of different races, ages, and gender, and discusses the use of sulfonylureas and other oral antihyperglycaemic agents.",Oral Antihyperglycaemics,https://doi.org/10.2165/00002512-199710050-00001,9143853
False," The study does not meet the inclusion criteria as it focuses on a single drug, glibenclamide, and its metabolites, and does not involve adults with type 2 diabetes.",Concentrationeffect relations of glibenclamide and its active metabolites in man modelling of Pharmacokinetics and Pharmacodynamics,https://doi.org/10.1046/j.1365-2125.1997.00571.x,9146849
True," The study meets all the inclusion criteria as it is a systematic review of the medical literature, includes adults with type 2 diabetes, and discusses clinically relevant outcomes such as quality of life and all-cause mortality.",Treatment of noninsulindependent diabetes mellitus with metformin,nan,9159660
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes treated with sulphonylureas.",Effect of Combination Therapy of Troglitazone and Sulphonylureas in Patients with Type Diabetes Who Were Poorly Controlled by Sulphonylurea Therapy Alone,https://doi.org/10.1002/(sici)1096-9136(199604)13:4<365::aid-dia19>3.0.co;2-m,9162613
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glipizide as the intervention, and reports clinically relevant outcomes.",GlipizideGITS Does Not Increase the Hypoglycemic Effect of Mild Exercise During Fasting in NIDDM,https://doi.org/10.2337/diacare.20.6.992,9167112
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glimepiride) as the intervention, and is a double-blind, randomized controlled trial in an outpatient setting.",ShortTerm Comparison of Once versus TwiceDaily Administration of Glimepiride in Patients with NonInsulinDependent Diabetes Mellitus,https://doi.org/10.1177/106002809703100601,9184703
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses glyburide as the intervention, and reports clinically relevant outcomes.",Pharmacokinetics of oral glyburide in subjects with noninsulindependent diabetes mellitus and renal failure,https://doi.org/10.1016/s0272-6386(97)90465-0,9186077
True," The study meets the inclusion criteria as it is a fair quality study on adults with type 2 diabetes (NIDDM) treated with insulin, and it reports original data on the effect of insulin treatment on circulating islet amyloid polypeptide.",Effect of insulin treatment on circulating islet amyloid polypeptide in patients with NIDDM,https://doi.org/10.1002/(sici)1096-9136(199706)14:6<472::aid-dia388>3.0.co;2-q,9212313
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, uses a sulfonylurea (tolbutamide) as an intervention, and reports clinically relevant outcomes such as all-cause mortality.",Glucose tolerance and mortality including a substudy of tolbutamide treatment,https://doi.org/10.1007/s001250050734,9222648
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glimepiride) as the intervention, and reports clinically relevant outcomes.",Beta Cell Response to Oral Glimepiride Administration During and Following a Hyperglycaemic Clamp in NIDDM Patients,https://doi.org/10.1002/(sici)1096-9136(199707)14:7<556::aid-dia389>3.0.co;2-6,9223393
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it contains original data.",Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance,https://doi.org/10.1172/jci119562,9239399
True," The study meets the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with adults with type 2 diabetes, and it investigates the effect of a sulfonylurea (glyburide) on clinically relevant outcomes.",The Influence of Bromfenac on the Pharmacokinetics and Pharmacodynamic Responses to Glyburide in Diabetic Subjects,nan,9250558
True," The study meets all the inclusion criteria as it is a fair quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glibenclamide) as the intervention, and reports clinically relevant outcomes such as changes in leptin concentrations.",Glibenclamide but Not Acarbose Increases Leptin Concentrations Parallel to Changes in Insulin in Subjects With NIDDM,https://doi.org/10.2337/diacare.20.9.1430,9283792
False," The article does not contain original data, as it is a review of the pathophysiology of type diabetes and potential therapeutic interventions, and does not present any new or original research findings.",Pathophysiology of Type Diabetes and Modes of Action of Therapeutic Interventions,https://doi.org/10.1001/archinte.1997.00440370028004,9290539
True," The study meets all the inclusion criteria as it is a good quality study of adults with type 2 diabetes treated with sulfonylureas, specifically gliclazide, and includes clinically relevant outcomes.",Monitoring of metabolic control in patients with noninsulindependent diabetes mellitus on oral hypoglycaemic agents value of evening blood glucose determination,https://doi.org/10.1002/(sici)1096-9136(199709)14:9<798::aid-dia420>3.0.co;2-c,9300232
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses sulfonylurea therapy, and is a double-blind, randomized controlled trial in an outpatient setting.",Relative Hyperproinsulinemia of NIDDM Persists Despite the Reduction of Hyperglycemia With Insulin or Sulfonylurea Therapy,https://doi.org/10.2337/diacare.46.10.1557,9313749
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (glibenclamide) as the intervention, and reports clinically relevant outcomes related to lipoprotein metabolism.",Insulin and Sulfonylurea Therapy in NIDDM Patients Are the Effects on Lipoprotein Metabolism Different Even With Similar Blood Glucose Control,https://doi.org/10.2337/diacare.46.10.1601,9313756
True," The study meets all the inclusion criteria as it is a systematic review of metformin's effects on type 2 diabetes, includes adults of different races, ages, and genders, and focuses on clinically relevant outcomes.",Die Stellung der Biguanide in der Therapie des Diabetes mellitus,https://doi.org/10.1007/bf03044916,9340472
True," The study meets the inclusion criteria as it is a double-blind crossover study in healthy male subjects investigating the pharmacokinetics of glibenclamide with and without voglibose, and it reports original data.",Concomitant administration of the glucosidase inhibitor voglibose AO does not alter the pharmacokinetics of glibenclamide,https://doi.org/10.1007/s002280050354,9403288
True," The study meets the inclusion criteria as it is a fair quality study that includes adults with type 2 diabetes, uses a relevant intervention (lithium), and reports clinically relevant outcomes.",Assisting effects of lithium on hypoglycemic treatment in patients with diabetes,https://doi.org/10.1007/bf02783316,9404682
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, and it reports original data on the effects of metformin in patients treated with sulfonylureas.",Results of a PlaceboControlled Study of the Metabolic Effects of the Addition of Metformin to SulfonylureaTreated Patients Evidence for a central role of adipose tissue,https://doi.org/10.2337/diacare.20.12.1863,9405908
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses sulfonylureas as an intervention, and is a double-blind, randomized controlled trial in an outpatient setting.",A Prospective Trial of Risk Factors for SulfonylureaInduced Hypoglycemia in Type Diabetes Mellitus,https://doi.org/10.1001/jama.279.2.137,9440664
False, The article does not contain original data as it appears to be a review of existing knowledge on sulfonamides.,Pharmacokinetics of hypoglycemic sulfonamides Ozidia a new concept,nan,9463023
True," The study meets the inclusion criteria as it is a good quality study of adults with type 2 diabetes, specifically investigating the pharmacokinetics of glyburide in an outpatient setting.",Population Pharmacokinetics of Glyburide in Patients with WellControlled Diabetes,nan,9469681
False," The study focuses on children with NIDDM, not adults, and does not meet the criteria for the type of intervention (sulfonylureas or short-acting secretagogues).",Treatment of NIDDM in Youth,https://doi.org/10.1177/000992289803700209,9492120
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses a sulfonylurea (gliclazide) as the intervention, and reports clinically relevant outcomes.",Molecular effects of sulphonylurea agents in circulating lymphocytes of patients with noninsulindependent diabetes mellitus,https://doi.org/10.1046/j.1365-2125.1998.00680.x,9517374
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it investigates the effect of a specific oral hypoglycemic drug (picotamide) on microvascular disease in type 2 diabetic patients.",Longterm treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type diabetic patients,https://doi.org/10.2337/diabetes.47.3.423,9519749
False," The study does not meet the inclusion criteria as it is not a systematic review or double-blind, randomized controlled trial, but rather a narrative review of existing studies.",Is There a ConcentrationEffect Relationship for Sulphonylureas,https://doi.org/10.2165/00003088-199834030-00001,9533980
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a randomized controlled trial, it involves adults with type 2 diabetes, and it examines clinically relevant outcomes.",The Effect of Short Periods of Caloric Restriction on Weight Loss and Glycemic Control in Type Diabetes,https://doi.org/10.2337/diacare.21.1.2,9538962
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes.",UKPDS A Randomized Trial of Efficacy of Early Addition of Metformin in SulfonylureaTreated Type Diabetes,https://doi.org/10.2337/diacare.21.1.87,9538975
False," The study does not meet the inclusion criteria for intervention as it only includes glibenclamide, a sulfonylurea, and does not include other sulfonylureas or short-acting secretagogues.",The blood glucose lowering effects of exercise and glibenclamide in patients with Type diabetes mellitus,https://doi.org/10.1002/(sici)1096-9136(199803)15:3<194::aid-dia546>3.0.co;2-2,9545119
False," The study does not focus on adults with type 2 diabetes, but rather on the impact of smoking cessation.",Modeling allcause mortality projections of the impact of smoking cessation based on the NHEFS NHANES I Epidemiologic Followup Study,https://doi.org/10.2105/ajph.88.4.630,9551006
True," The study contains original data and is a systematic review of glimepiride, meeting the inclusion criteria for a study on sulfonylureas.",Glimepiride,https://doi.org/10.2165/00003495-199855040-00007,9561345
True," The study meets all the inclusion criteria as it is a prospective natural history study of adults with type 2 diabetes, assessing the effect of intensive dietary management, and reports clinically relevant outcomes.",Betacell deterioration determines the onset and rate of progression of secondary dietary failure in Type diabetes mellitus the year followup of the Belfast Diet Study,https://doi.org/10.1002/(sici)1096-9136(199804)15:4<290::aid-dia570>3.0.co;2-m,9585393
True," The study meets all the inclusion criteria as it is a systematic review of a randomized controlled trial of sulphonylureas in patients with type 2 diabetes, and it reports on clinically relevant outcomes.",UKPDS sulphonylurea failure in noninsulindependent diabetic patients over six years,https://doi.org/10.1002/(sici)1096-9136(199804)15:4<297::aid-dia572>3.0.co;2-w,9585394
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, and it investigates the effect of magnesium supplementation on patients with type 2 diabetes.",The Effect of Magnesium Supplementation in Increasing Doses on the Control of Type Diabetes,https://doi.org/10.2337/diacare.21.5.682,9589224
True," The study meets all the inclusion criteria as it is a good quality study, involves adults with type 2 diabetes, uses sulfonylurea as an intervention, and reports clinically relevant outcomes.",Changes in Amylin and AmylinLike Peptide Concentrations ana Cell Function in Response to Sulfonylurea or Insulin Therapy in NIDDM,https://doi.org/10.2337/diacare.21.5.810,9589246
True," The study meets all the inclusion criteria as it is a fair quality study that includes adults with type 2 diabetes, uses a relevant intervention (oral hypoglycemic agents), and reports clinically relevant outcomes.",Oxidative stress and metabolic control in noninsulin dependent diabetes mellitus,nan,9594432
True," The study meets all the inclusion criteria as it is a double-blind crossover placebo-controlled trial involving adults with type 2 diabetes, and it reports on clinically relevant outcomes.",Effect of acarbose in treatment of type II diabetes mellitus a doubleblind crossover placebocontrolled trial,nan,9623011
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes.",Beginning Insulin Treatment of Obese Patients With Evening Insulin Plus Glimepiride Versus Insulin Alone,https://doi.org/10.2337/diacare.21.7.1052,9653594
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes treated with conventional oral agents.",Acarbose in NIDDM Patients With Poor Control on Conventional Oral Agents A week placebocontrolled study,https://doi.org/10.2337/diacare.21.7.1154,9653611
True," The study meets all the inclusion criteria as it is a good quality study, involves oral administration of a sulfonylurea (gliclazide), and reports clinically relevant outcomes.",Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG suspension of gliclazide,https://doi.org/10.1016/s0168-3659(97)00167-3,9685916
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, and examines the risk of fatal cardiovascular disease in older women and men.",Isolated Postchallenge Hyperglycemia and the Risk of Fatal Cardiovascular Disease in Older Women and Men The Rancho Bernardo Study,https://doi.org/10.2337/diacare.21.8.1236,9702426
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial of glimepiride in adults with type 2 diabetes, and it reports clinically relevant outcomes.",A PlaceboControlled Randomized Study of Glimepiride in Patients with Type Diabetes Mellitus for Whom Diet Therapy is Unsuccessful,https://doi.org/10.1002/j.1552-4604.1998.tb04471.x,9702849
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a double-blind, randomized controlled trial, it involves adults with type 2 diabetes, and it assesses clinically relevant outcomes.",Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type Diabetes,https://doi.org/10.2337/diacare.21.9.1462,9727892
False, The abstract does not mention the inclusion criteria of intervention by sulfonylureas or short-acting secretagogues.,Metformin An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium,https://doi.org/10.1159/000381643,9732337
True," The study meets all the inclusion criteria as it is a systematic review of repaglinide, a short-acting secretagogue, in patients with type 2 diabetes, and it reports on clinically relevant outcomes.",Repaglinide,https://doi.org/10.2165/00002512-199813020-00008,9739505
False, The study does not meet the inclusion criteria as it is focused on children and does not involve adults with type 2 diabetes.,Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children,https://doi.org/10.1159/000444053,9742976
False," The abstract does not contain original data, as it appears to be a general overview of oral antidiabetic agents rather than a systematic review or a study with original data.",Pitfalls in treatment with oral antidiabetic agents,nan,9750481
True," The study meets the inclusion criteria as it is a systematic review of prospective evidence on tight glycemic control in people with type 2 diabetes, focusing on clinically relevant outcomes such as microvascular disease and quality of life.",Issues Surrounding Tight Glycemic Control in People with Type Diabetes Mellitus,https://doi.org/10.1345/aph.17375,9762378
False, The abstract does not mention the specific inclusion criteria of sulfonylureas or short-acting secretagogues as the intervention.,New therapies in type diabetes,nan,9789590
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial (crossover design) in an outpatient setting, and it investigates the effects of a sulfonylurea (glibenclamide) on clinically relevant outcomes in adults with type 2 diabetes.",Effects of glibenclamide on blood pressure and cardiovascular responsiveness in noninsulin dependent diabetes mellitus,https://doi.org/10.1097/00004872-199816050-00019,9797183
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it reports original data on the efficacy and safety of repaglinide in the treatment of type 2 diabetes.",A randomized placebocontrolled trial of repaglinide in the treatment of type diabetes,https://doi.org/10.2337/diacare.21.11.1897,9802740
True," The study meets all the inclusion criteria as it is a good quality study, includes adults with type 2 diabetes, and examines the effect of glucagon-like peptide on fasting glycemia in patients treated with insulin after sulfonylurea secondary failure.",Influence of glucagonlike peptide on fasting glycemia in type diabetic patients treated with insulin after sulfonylurea secondary failure,https://doi.org/10.2337/diacare.21.11.1925,9802745
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it involves the use of a sulfonylurea (glibenclamide) as the intervention.",Clinical study of glibenclamide in combination with kelening treatment in noninsulin dependent diabetes mellitus,nan,9812648
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting with clinically relevant outcomes, and it includes adults with type 2 diabetes.",Reduction of oxidative stress by oral NacetylLcysteine treatment decreases plasma soluble vascular cell adhesion molecule concentrations in nonobese nondyslipidaemic normotensive patients with noninsulindependent diabetes,https://doi.org/10.1007/s001250051082,9833950
True," The study meets all the inclusion criteria as it is a double-blind, randomized controlled trial in an outpatient setting, includes adults with type 2 diabetes treated with sulfonylureas or short-acting secretagogues, and reports clinically relevant outcomes.",Highfat versus highcarbohydrate enteral formulae effect on blood glucose CPeptide and ketones in patients with type diabetes treated with insulin or sulfonylurea,https://doi.org/10.1016/s0899-9007(98)00124-5,9834926
False," The study does not meet the inclusion criteria as it focuses on IDDM (Insulin-Dependent Diabetes Mellitus, now known as Type 1 diabetes) rather than Type 2 diabetes.",Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment,https://doi.org/10.2337/diabetes.47.12.1909,9836523
True," The study meets all the inclusion criteria as it is a systematic investigation of the impact of nocturnal hypoglycemia on cognitive function in patients with type 2 diabetes, using a double-blind, randomized controlled trial design in an outpatient setting.",Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type diabetes,https://doi.org/10.2337/diabetes.47.12.1920,9836525
True," The study meets the inclusion criteria as it is a systematic review of studies on restricting home glucose monitoring strips in patients taking oral antidiabetic agents, specifically sulfonylureas and short-acting secretagogues, in an outpatient setting.",Restricting home glucosemonitoring strips in patients taking oral antidiabetic agents,https://doi.org/10.1093/ajhp/55.23.2509,9853636
True," The study meets the inclusion criteria as it is a randomized controlled trial investigating the effect of insulin treatment on retinopathy in elderly type 2 diabetic patients, and it reports original data.",Insulin treatment of elderly type diabetic patients effects on retinopathy,nan,9881243
False," The study does not meet the inclusion criteria for intervention type, as it involves insulin (a basal insulin) rather than sulfonylureas or short-acting secretagogues.",Effects of regular insulin or insulin LISPRO on glucose metabolism after an oral glucose load in patients with type diabetes mellitus,nan,9932219
True," The study meets all the inclusion criteria as it is a systematic review is not mentioned but it is a crossover study which is a type of double-blind, randomized controlled trial, and it includes clinically relevant outcomes such as quality of life.",Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas Is it predictable,https://doi.org/10.1007/bf03348039,9972673
True," The study meets all the inclusion criteria as it is a retrospective study of adults with type 2 diabetes treated with sulfonylureas and short-acting secretagogues, and it reports clinically relevant outcomes such as morbidity and mortality.",DrugInduced Hypoglycemic Coma in Diabetic Patients,https://doi.org/10.1001/archinte.159.3.281,9989540
